The proteasomal system.
暂无分享,去创建一个
[1] P. Elliott,et al. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. , 2001, International journal of radiation oncology, biology, physics.
[2] N. Chondrogianni,et al. Proteasome activation as a novel antiaging strategy , 2008, IUBMB life.
[3] S. Hayashi. Antizyme-dependent degradation of ornithine decarboxylase. , 1995, Essays in biochemistry.
[4] K. Schwarz,et al. Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver1 , 2001, The Journal of Immunology.
[5] R. Derynck,et al. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] F. Tortella,et al. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: Relation to nuclear factor κB (NF-κB), inflammatory gene expression, and leukocyte infiltration , 2006, Neurochemistry International.
[7] P. Kinnunen,et al. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). , 2001, European journal of biochemistry.
[8] S. Matsufuji,et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.
[9] X. Zou,et al. The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics , 2006, The Journal of general physiology.
[10] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[11] D. Haines,et al. Cdc48p(Npl4p/Ufd1p) binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors. , 2007, Molecular cell.
[12] A. Kisselev. Joining the army of proteasome inhibitors. , 2008, Chemistry & biology.
[13] J. Tobias,et al. The N-end rule in Escherichia coli: cloning and analysis of the leucyl, phenylalanyl-tRNA-protein transferase gene aat , 1993, Journal of bacteriology.
[14] J. Brodsky,et al. Dissecting the ER-Associated Degradation of a Misfolded Polytopic Membrane Protein , 2008, Cell.
[15] Patricia A. Pioli,et al. The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression* , 2001, The Journal of Biological Chemistry.
[16] I. Mook‐Jung,et al. Amyloid peptide attenuates the proteasome activity in neuronal cells , 2005, Mechanisms of Ageing and Development.
[17] Michele Pagano,et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. , 2006, Molecular cell.
[18] B. Seilheimer,et al. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis‐like disease , 2006, Journal of neuroscience research.
[19] J. Monaco,et al. T Cells Lacking Immunoproteasome Subunits MECL-1 and LMP7 Hyperproliferate in Response to Polyclonal Mitogens1 , 2006, The Journal of Immunology.
[20] P. Beer-Romero,et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.
[21] J. Freedman,et al. A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation. , 1998, The Biochemical journal.
[22] R. Youle,et al. Outer Mitochondrial Membrane Protein Degradation by the Proteasome , 2007 .
[23] K. Davies,et al. Dityrosine: a marker for oxidatively modified proteins and selective proteolysis. , 1994, Methods in enzymology.
[24] B. Friguet,et al. Enzymatic reactions involved in the repair of oxidized proteins , 2004, Experimental Gerontology.
[25] B. Friguet,et al. Algae extract-mediated stimulation and protection of proteasome activity within human keratinocytes exposed to UVA and UVB irradiation. , 2006, Antioxidants & redox signaling.
[26] K. Davies,et al. 4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease* , 2000, Cellular and Molecular Life Sciences CMLS.
[27] J. Slack,et al. Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. , 2000, Molecular cell biology research communications : MCBRC.
[28] W. Miller,et al. Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism , 2004, Oncogene.
[29] M. Angeletti,et al. Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems. , 2003, Free radical biology & medicine.
[30] S. Itohara,et al. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. , 2004, Human molecular genetics.
[31] M. Tuite,et al. Protein disulphide isomerase: building bridges in protein folding. , 1994, Trends in biochemical sciences.
[32] L. Hendershot,et al. BiP mutants that are unable to interact with endoplasmic reticulum DnaJ proteins provide insights into interdomain interactions in BiP , 2008, Proceedings of the National Academy of Sciences.
[33] Richard Weindruch,et al. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] Hubert Kimmig,et al. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17) , 2007, Neurology.
[35] G N DeMartino,et al. Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome). , 1991, Biochemistry.
[36] R. Tennant,et al. Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. , 2008, Journal of molecular biology.
[37] S. Elledge,et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.
[38] P. Crack,et al. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. , 2008, Current medicinal chemistry.
[39] A. Nunomura,et al. Oxidative damage in Alzheimer’s disease: the metabolic dimension , 2000, International Journal of Developmental Neuroscience.
[40] Lars I Leichert,et al. Protein Thiol Modifications Visualized In Vivo , 2004, PLoS biology.
[41] Yoram Louzoun,et al. Precise score for the prediction of peptides cleaved by the proteasome , 2008, Bioinform..
[42] L. Claesson‐Welsh,et al. Expression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma , 1996, Journal of neuropathology and experimental neurology.
[43] Martin Rechsteiner,et al. Recognition of the polyubiquitin proteolytic signal , 2000, The EMBO journal.
[44] P. Mcgeer,et al. Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity , 2005, Glia.
[45] M. Rechsteiner,et al. Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? , 2003, The international journal of biochemistry & cell biology.
[46] K. Tanaka,et al. The NH2‐terminal residues of rat liver proteasome (multicatalytic proteinase complex) subunits, C2, C3 and C8, are Nα‐acetylated , 1990, FEBS Letters.
[47] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.
[48] W. Markesbery,et al. Proteasome inhibition results in increased poly‐ADP‐ribosylation: Implications for neuron death , 2000, Journal of neuroscience research.
[49] M. Stitzel,et al. The proteasome regulates the UV-induced activation of the AP-1-like transcription factor Gcn4. , 2001, Genes & development.
[50] R. Tampé,et al. Intracellular peptide transporters in human – compartmentalization of the “peptidome” , 2007, Pflügers Archiv - European Journal of Physiology.
[51] A. Goldberg,et al. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator. , 1996, European journal of biochemistry.
[52] U. Aebi,et al. The Human α-Type Proteasomal Subunit HsC8 Forms a Double Ringlike Structure, but Does Not Assemble into Proteasome-like Particles with the β-Type Subunits HsDelta or HsBPROS26* , 1997, The Journal of Biological Chemistry.
[53] Y. Murakami,et al. Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.
[54] B. Keller,et al. Cu/Zn Superoxide Dismutase Typical for Familial Amyotrophic Lateral Sclerosis Increases the Vulnerability of Mitochondria and Perturbs Ca2+ Homeostasis in SOD1G93A Mice , 2009, Molecular Pharmacology.
[55] Y. Murakami,et al. ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome. , 1994, The Journal of biological chemistry.
[56] U. Brunk,et al. Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.
[57] V. Pérez,et al. Proteasome modulates mitochondrial function during cellular senescence. , 2008, Free radical biology & medicine.
[58] P. Lansbury,et al. Reversible Monoubiquitination Regulates the Parkinson Disease-associated Ubiquitin Hydrolase UCH-L1*♦ , 2007, Journal of Biological Chemistry.
[59] R. Eckel,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. , 2002, Circulation.
[60] Günter J. Hämmerling,et al. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex , 1991, Nature.
[61] D. Price,et al. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.
[62] Claudine Jurkovitz,et al. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. , 1999, American journal of physiology. Cell physiology.
[63] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[64] J. White,et al. Proteasome Activator PA200 Is Required for Normal Spermatogenesis , 2006, Molecular and Cellular Biology.
[65] E. Mazzon,et al. Protective effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat. , 1999, Biochemical pharmacology.
[66] K. Anderson,et al. Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. , 2006, Blood.
[67] Mark R. Segal,et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.
[68] T. Kodadek,et al. The proteasomal ATPase complex is required for stress-induced transcription in yeast , 2006, Nucleic acids research.
[69] D. Masison,et al. Prion-impairing mutations in Hsp70 chaperone Ssa1: effects on ATPase and chaperone activities. , 2008, Archives of biochemistry and biophysics.
[70] U. Brunk,et al. Oxidative stress, accumulation of biological 'garbage', and aging. , 2006, Antioxidants & redox signaling.
[71] M. Beal,et al. Mitochondrial dysfunction and amyotrophic lateral sclerosis , 2006, Muscle & nerve.
[72] M. Latterich,et al. p97: The cell's molecular purgatory? , 2006, Molecular cell.
[73] M. Portero-Otín,et al. Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation , 2005, Journal of Biological Chemistry.
[74] G. Stamp,et al. Early Postnatal Death and Motor Disorders in Mice Congenitally Deficient in Calnexin Expression , 2002, Molecular and Cellular Biology.
[75] J. Harris. Release of a macromolecular protein component from human erythrocyte ghosts. , 1968, Biochimica et biophysica acta.
[76] K. Hendil,et al. Proteasome subunit zeta, a putative ribonuclease, is also found as a free monomer , 1999, Molecular Biology Reports.
[77] D. Livingston,et al. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. , 1996, Genes & development.
[78] D. Wolf,et al. A genomic screen identifies Dsk2p and Rad23p as essential components of ER‐associated degradation , 2004, EMBO reports.
[79] J. Buchner,et al. Cns1 Is an Activator of the Ssa1 ATPase Activity* , 2004, Journal of Biological Chemistry.
[80] A. Goldberg,et al. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. , 1995, The American journal of physiology.
[81] K. Davies,et al. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.
[82] Cam Patterson,et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[83] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[84] A. Buchberger,et al. Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation , 2005, Nature Cell Biology.
[85] G. Paolisso,et al. Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture. , 2007, Circulation research.
[86] A. Manning,et al. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. , 1995, Journal of immunology.
[87] K. Davies,et al. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. , 1993, The Journal of biological chemistry.
[88] D. Giugliano,et al. Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase , 2004, Journal of thrombosis and haemostasis : JTH.
[89] A. Hershko,et al. Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[90] O. Sommerburg,et al. Influence of DNA binding on the degradation of oxidized histones by the 20S proteasome. , 1999, Archives of biochemistry and biophysics.
[91] T. Hirano,et al. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells. , 2000, Blood.
[92] P. Lehner. The calculus of immunity: quantitating antigen processing. , 2003, Immunity.
[93] D. Butterfield,et al. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.
[94] A. Rembach,et al. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS , 2004, Journal of neuroscience research.
[95] P. van Endert,et al. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues , 2008, Journal of cellular physiology.
[96] C. Olanow,et al. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats , 2002, Neuroreport.
[97] C. Ireland,et al. Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. , 2004, Journal of medicinal chemistry.
[98] G. Wolf. Lipofuscin, the age pigment. , 2009, Nutrition reviews.
[99] R. Huber,et al. Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. , 1999, Journal of molecular biology.
[100] R. Gavioli,et al. Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit. , 2007, European journal of medicinal chemistry.
[101] Daniel Offen,et al. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage , 2006, Neuroscience Letters.
[102] Michael D. George,et al. A protein conjugation system essential for autophagy , 1998, Nature.
[103] K. Takahashi,et al. TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087. , 2000, The Journal of antibiotics.
[104] K. Pelin,et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.
[105] R. Kopito,et al. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. , 2002, The Journal of clinical investigation.
[106] Manuela M. Santos,et al. Gene expression profiling in frataxin deficient mice: Microarray evidence for significant expression changes without detectable neurodegeneration , 2006, Neurobiology of Disease.
[107] D. Spasic,et al. Rer1p competes with APH-1 for binding to nicastrin and regulates γ-secretase complex assembly in the early secretory pathway , 2007, The Journal of cell biology.
[108] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[109] P. Kloetzel,et al. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. , 2004, Current opinion in immunology.
[110] Santanu Acharya,et al. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation. , 2008, International immunology.
[111] W. D. de Jong,et al. The human proteasomal subunit HsC8 induces ring formation of other alpha-type subunits. , 1998, Journal of molecular biology.
[112] M. Pagano,et al. Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation , 1998, Molecular and Cellular Biology.
[113] W. Mitch,et al. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. , 1994, The American journal of physiology.
[114] B. Friguet,et al. Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.
[115] G. Kroemer,et al. Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function , 1997, European journal of immunology.
[116] J. Cooper. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. , 2003 .
[117] K. Davies,et al. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I— effects of proliferative senescence , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[118] L. Lerman,et al. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. , 2008, Journal of the American College of Cardiology.
[119] J. Cusack,et al. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.
[120] M. Atkins,et al. Targeting the Mitogen-Activated Protein Kinase Pathway in the Treatment of Malignant Melanoma , 2006, Clinical Cancer Research.
[121] P. Cresswell,et al. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.
[122] S. Ommen,et al. Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. , 2005, Molecular genetics and metabolism.
[123] J. Sjöstrand,et al. Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation. , 1999, Experimental eye research.
[124] A. Parodi,et al. Quality control and protein folding in the secretory pathway. , 2003, Annual review of cell and developmental biology.
[125] A. Rivett,et al. Purification of a liver alkaline protease which degrades oxidatively modified glutamine synthetase. Characterization as a high molecular weight cysteine proteinase. , 1985, The Journal of biological chemistry.
[126] C. Masters,et al. Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease , 2008 .
[127] D. Green,et al. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. , 2000, Cancer research.
[128] R. Sunahara,et al. Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation. , 2005, Biochemistry.
[129] M. Tatham,et al. Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9* , 2001, The Journal of Biological Chemistry.
[130] J. Sarsero,et al. Evaluation of an FRDA–EGFP genomic reporter assay in transgenic mice , 2005, Mammalian Genome.
[131] F. Meyer,et al. Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[132] B Chance,et al. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.
[133] R. Hampton,et al. Determinants of RING-E2 Fidelity for Hrd1p, a Membrane-anchored Ubiquitin Ligase* , 2006, Journal of Biological Chemistry.
[134] H. Sies. Oxidative stress: from basic research to clinical application. , 1991, The American journal of medicine.
[135] H. Ploegh,et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.
[136] M. Muller,et al. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. , 2006, Free radical biology & medicine.
[137] Yunbi Lu,et al. Production of matrix metalloproteinase‐9 by activated human monocytes involves a phosphatidylinositol‐3 kinase/Akt/IKKα/NF‐κB pathway , 2005, Journal of leukocyte biology.
[138] M. Molinari,et al. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER , 2002, The Journal of cell biology.
[139] Aiqing He,et al. The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[140] B. Friguet,et al. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. , 1994, Archives of biochemistry and biophysics.
[141] A. Goldberg,et al. Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.
[142] C. Hill,et al. Identification of an activation region in the proteasome activator REGalpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[143] P. Kloetzel,et al. A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. , 1999, Journal of molecular biology.
[144] M. Koenig,et al. Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.
[145] Tilman Grune,et al. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains , 2006, Neurobiology of Aging.
[146] Martin von Bergen,et al. Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation. , 2007, Journal of the American Chemical Society.
[147] G. Blair,et al. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins , 2000, Oncogene.
[148] R. Klausner,et al. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[149] H. Withers,et al. Molecular Pathways That Modify Tumor Radiation Response , 2001, American journal of clinical oncology.
[150] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[151] S. Wolff. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. , 1993, British medical bulletin.
[152] K. Scharffetter-Kochanek,et al. Psoralen plus UVA (PUVA) induced premature senescence as a model for stress-induced premature senescence , 2002, Experimental Gerontology.
[153] Kenta Okamoto,et al. Dissecting β‐ring assembly pathway of the mammalian 20S proteasome , 2008, The EMBO journal.
[154] D. Butterfield,et al. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.
[155] O. Mandelboim,et al. Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading , 2002, The Journal of Immunology.
[156] T. Montine,et al. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.
[157] B. Friguet,et al. Age-related alterations of proteasome structure and function in aging epidermis , 2000, Experimental Gerontology.
[158] B. Friguet. Protein Repair and Degradation during Aging , 2002, TheScientificWorldJournal.
[159] B. Friguet,et al. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors. , 2008, Biochimie.
[160] J. Remacle,et al. Establishment of H2O2‐Induced Premature Senescence in Human Fibroblasts Concomitant with Increased Cellular Production of H2O2 , 2006, Annals of the New York Academy of Sciences.
[161] M. Schmitz,et al. NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer , 2007 .
[162] M. Brownlee,et al. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. , 1990, Biochemical and biophysical research communications.
[163] J. Andersen,et al. Glutathione, iron and Parkinson's disease. , 2002, Biochemical pharmacology.
[164] A. Rivett,et al. Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities* , 1997, The Journal of Biological Chemistry.
[165] G. Krissansen,et al. Temporal Expression of Heat Shock Proteins 60 and 70 at Lesion-Prone Sites During Atherogenesis in ApoE-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[166] H. Engelhard,et al. Ciliary neurotrophic factor upregulates ubiquitin-proteasome components in a rat model of neuronal injury. , 2004, Cytokine.
[167] M. Salmona,et al. Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2005, Journal of Biological Chemistry.
[168] P. Piccini,et al. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) , 2005, Movement disorders : official journal of the Movement Disorder Society.
[169] S. J. Upton,et al. Cloning and Molecular Characterization of a Gene Encoding a Cryptosporidium parvum Putative 20s Proteasome β1—Type Subunit , 2000 .
[170] J. Sastre,et al. Glutathione Regulates Telomerase Activity in 3T3 Fibroblasts* , 2004, Journal of Biological Chemistry.
[171] S. Humbert,et al. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic? , 2004, Pathologie-biologie.
[172] L. Tutar,et al. Ydj1 but not Sis1 stabilizes Hsp70 protein under prolonged stress in vitro , 2008, Biopolymers.
[173] P. Kloetzel,et al. The N-terminal Flanking Region of the TRP2360–368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation* , 2007, Journal of Biological Chemistry.
[174] J. Ritz,et al. Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. , 2001, Blood.
[175] R. Rudolph,et al. Catalytic Activity and Chaperone Function of Human Protein-disulfide Isomerase Are Required for the Efficient Refolding of Proinsulin* , 2002, The Journal of Biological Chemistry.
[176] A. Koff,et al. The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. , 2002, The Biochemical journal.
[177] P. Elliott,et al. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[178] P. Woodman. p97, a protein coping with multiple identities , 2003, Journal of Cell Science.
[179] C. Fan,et al. A foldable CFTRΔF508 biogenic intermediate accumulates upon inhibition of the Hsc70–CHIP E3 ubiquitin ligase , 2004, The Journal of cell biology.
[180] R. Wetzel,et al. Solubilization and disaggregation of polyglutamine peptides , 2001, Protein science : a publication of the Protein Society.
[181] Xin Eric Wang,et al. Vitamin E and its function in membranes. , 1999, Progress in lipid research.
[182] R. Huber,et al. A gated channel into the proteasome core particle , 2000, Nature Structural Biology.
[183] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[184] M. Hochstrasser,et al. Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways , 2006, The EMBO journal.
[185] P. Lansbury,et al. Substrate recognition and catalysis by UCH-L1. , 2006, Biochemistry.
[186] S. Kim,et al. Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity , 2003 .
[187] A. Paolicchi,et al. Glutathione catabolism as a signaling mechanism. , 2002, Biochemical pharmacology.
[188] U. Brunk,et al. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. , 1997, Free radical biology & medicine.
[189] P. Flakoll,et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. , 2002, The Journal of clinical investigation.
[190] W. Xiao,et al. The TRAF6 RING finger domain mediates physical interaction with Ubc13 , 2004, FEBS letters.
[191] L. Lerman,et al. Chronic Proteasome Inhibition Contributes to Coronary Atherosclerosis , 2007, Circulation research.
[192] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[193] S. Fey,et al. Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. , 2002, Biochemical pharmacology.
[194] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[195] I. Grundke‐Iqbal,et al. Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like State , 1995, Journal of neurochemistry.
[196] S. Orrenius,et al. Redox regulation of apoptotic cell death , 1998, BioFactors.
[197] F. Cognetti,et al. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. , 2000, Journal of experimental & clinical cancer research : CR.
[198] M. Stanton,et al. Cystic fibrosis mortality and survival in the UK: 1947–2003 , 2007, European Respiratory Journal.
[199] L. Pasquini,et al. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase‐3 in cultured cerebellar granule cells , 2000, Journal of neuroscience research.
[200] B. Friguet,et al. Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe–S proteins , 2009, The FEBS journal.
[201] R. Moon,et al. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.
[202] R. Brigelius-Flohé,et al. Selenium-dependent enzymes in endothelial cell function. , 2003, Antioxidants & redox signaling.
[203] Kenta Okamoto,et al. Crystal structure of a chaperone complex that contributes to the assembly of yeast 20S proteasomes , 2008, Nature Structural &Molecular Biology.
[204] M. Kasahara,et al. Growth Retardation in Mice Lacking the Proteasome Activator PA28γ* , 1999, The Journal of Biological Chemistry.
[205] C. Masters,et al. Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[206] Richard S. Rogers,et al. A conserved catalytic residue in the ubiquitin‐conjugating enzyme family , 2003, The EMBO journal.
[207] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[208] J. Zieleński,et al. Cystic fibrosis: genotypic and phenotypic variations. , 1995, Annual review of genetics.
[209] J. Ávila,et al. Extracellular tau is toxic to neuronal cells , 2006, FEBS letters.
[210] J. Yewdell,et al. Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.
[211] D. Zaiss,et al. Rates of Processing Determine the Immunogenicity of Immunoproteasome-Generated Epitopes1 , 2007, The Journal of Immunology.
[212] T. Reinheckel,et al. Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress , 1995, The Journal of Biological Chemistry.
[213] Rieko Setsuie,et al. The functions of UCH-L1 and its relation to neurodegenerative diseases , 2007, Neurochemistry International.
[214] G. Paolisso,et al. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes , 2007, Cardiovascular diabetology.
[215] S. W. Lin,et al. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. , 1987, The Journal of biological chemistry.
[216] David H. Cribbs,et al. Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.
[217] K. Rock,et al. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[218] Liang Ge,et al. Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. , 2007, Cell metabolism.
[219] Robert M Friedlander,et al. Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.
[220] C. McLendon,et al. Cerebrovascular endothelial dysfunction mediated by β‐amyloid , 1997 .
[221] S. Waldman,et al. Guanylyl cyclases and signaling by cyclic GMP. , 2000, Pharmacological reviews.
[222] I. Wada,et al. EDEM3, a Soluble EDEM Homolog, Enhances Glycoprotein Endoplasmic Reticulum-associated Degradation and Mannose Trimming* , 2006, Journal of Biological Chemistry.
[223] R. Singh,et al. UBE1L2, a Novel E1 Enzyme Specific for Ubiquitin*♦ , 2007, Journal of Biological Chemistry.
[224] B. Ames,et al. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. , 2002, Neurotoxicology.
[225] Nongluk Plongthongkum,et al. Ire1 regulated XBP1 mRNA splicing is essential for the unfolded protein response (UPR) in Drosophila melanogaster. , 2007, Biochemical and biophysical research communications.
[226] T. Reinheckel,et al. Proteasome-dependent turnover of protein disulfide isomerase in oxidatively stressed cells. , 2002, Archives of biochemistry and biophysics.
[227] M. Figueiredo-Pereira,et al. A New Inhibitor of the Chymotrypsin‐Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin‐Protein Conjugates in a Neuronal Cell , 1994, Journal of neurochemistry.
[228] J. Harris. The isolation and purification of a macromolecular protein component from the human erythrocyte ghost. , 1969, Biochimica et biophysica acta.
[229] A. Rivett,et al. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. , 2004, The Biochemical journal.
[230] Geoffrey P Lewis,et al. Drusen-associated degeneration in the retina. , 2003, Investigative ophthalmology & visual science.
[231] F. R. Papa,et al. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene , 1993, Nature.
[232] S. Seregard,et al. Age-related maculopathy: pathogenetic features and new treatment modalities. , 2002, Acta ophthalmologica Scandinavica.
[233] A. Parant,et al. Cystic fibrosis mortality trends in France. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[234] Elke Krüger,et al. Interferon‐γ, the functional plasticity of the ubiquitin–proteasome system, and MHC class I antigen processing , 2005, Immunological reviews.
[235] A. Ciechanover,et al. Oxidative stress‐related increase in ubiquitination in early coronary atherogenesis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[236] M. Oren,et al. Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[237] T. Johnson,et al. Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. , 2008, The Biochemical journal.
[238] A. Hauschild,et al. Molecularly targeted therapy for melanoma , 2006, Cancer.
[239] Tony Hunter,et al. The regulation of transcription by phosphorylation , 1992, Cell.
[240] A. Gimson,et al. Cystic Fibrosis Liver Disease: To Transplant or Not to Transplant? , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[241] P. Richardson,et al. Novel therapies targeting the myeloma cell and its bone marrow microenvironment. , 2001, Seminars in oncology.
[242] T. N. Palmer,et al. Effect of acute and chronic alcohol treatment and their superimposition on lysosomal, cytoplasmic, and proteosomal protease activities in rat skeletal muscle in vivo. , 2002, Metabolism: clinical and experimental.
[243] E. Rodriguez-Boulan,et al. The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells , 2007, Proceedings of the National Academy of Sciences.
[244] A. Bush,et al. Metals and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[245] G. Sobue,et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. , 2009, Human molecular genetics.
[246] A. Emili,et al. β‐Subunit appendages promote 20S proteasome assembly by overcoming an Ump1‐dependent checkpoint , 2007, The EMBO journal.
[247] D. Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. , 2006, Journal of immunology.
[248] A. Rivett,et al. Regulation of proteasome complexes by γ-interferon and phosphorylation , 2001 .
[249] S. W. Lin,et al. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. , 1987, The Journal of biological chemistry.
[250] A. Goldberg,et al. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.
[251] Jeffrey N Keller,et al. Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.
[252] U. Rüb,et al. Spinocerebellar ataxia 2 (SCA2) , 2008, The Cerebellum.
[253] T. Sommer,et al. The Hrd1p ligase complex forms a linchpin between ER‐lumenal substrate selection and Cdc48p recruitment , 2006, The EMBO journal.
[254] P. Coffino,et al. Antizyme, a mediator of ubiquitin-independent proteasomal degradation. , 2001, Biochimie.
[255] A. Richmond,et al. Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells , 1997 .
[256] Wendy Bruening,et al. Up‐Regulation of Protein Chaperones Preserves Viability of Cells Expressing Toxic Cu/Zn‐Superoxide Dismutase Mutants Associated with Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[257] J. Fallon,et al. Up-regulation of the proteasome subunit LMP7 in tissues of endotoxemic rats. , 2000, The Journal of laboratory and clinical medicine.
[258] J. Blumberg,et al. Redox regulation of ubiquitin‐conjugating enzymes: mechanistic insights using the thiol‐specific oxidant diamide , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[259] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[260] Y. Jun,et al. Human Cytomegalovirus UL18 Utilizes US6 for Evading the NK and T-Cell Responses , 2008, PLoS pathogens.
[261] F. Tortella,et al. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. , 2000, Stroke.
[262] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[263] F. Momburg,et al. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57 , 2006, Nature Immunology.
[264] N. Breusing,et al. Regulation of proteasome-mediated protein degradation during oxidative stress and aging , 2008, Biological chemistry.
[265] R. Klausner,et al. The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells , 1999, Molecular and Cellular Biology.
[266] B. Friguet,et al. Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.
[267] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[268] B. Friguet,et al. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. , 1994, The Journal of biological chemistry.
[269] P. Kloetzel,et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.
[270] G. Martinelli,et al. Molecular therapy for multiple myeloma. , 2001, Haematologica.
[271] C. Lovati,et al. Spinocerebellar ataxia type 17 (SCA17): Oculomotor phenotype and clinical characterization of 15 Italian patients , 2007, Journal of Neurology.
[272] M. Orłowski,et al. Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes). , 1997, Biochemistry.
[273] R. Tanzi,et al. Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[274] A. Ashworth,et al. Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.
[275] J. Miller,et al. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. , 1998, Alcoholism, clinical and experimental research.
[276] O. Stemmann,et al. The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts , 2007, Journal of Cell Science.
[277] P. Kloetzel,et al. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[278] H. Ploegh,et al. Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. , 2006, Structure.
[279] E. Kabashi,et al. Failure of protein quality control in amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.
[280] K. Nakayama,et al. SCFβTrCP1 Activates and Ubiquitylates TAp63γ* , 2008, Journal of Biological Chemistry.
[281] Bernd Bukau,et al. The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies. , 2007, Trends in cell biology.
[282] G. Sobue,et al. Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1 , 2002, Brain Research.
[283] R. Marfella,et al. Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression. , 2008, Journal of the American College of Cardiology.
[284] M. Bevan. The Cutting Edge of T Cell Selection , 2007, Science.
[285] R. Dean,et al. Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.
[286] J. West-Mays,et al. Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation. , 2004, Investigative ophthalmology & visual science.
[287] Denham Harman,et al. The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.
[288] S. Lovestone,et al. Neurofibrillary tangles and tau phosphorylation. , 2001, Biochemical Society symposium.
[289] Peter T Lansbury,et al. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. , 2003, Chemistry & biology.
[290] A. Cuervo,et al. A2E, a pigment of RPE lipofuscin, is generated from the precursor, A2PE by a lysosomal enzyme activity. , 2008, Advances in experimental medicine and biology.
[291] J. Fischer,et al. Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis. , 1991, Surgery.
[292] M. Tomonaga,et al. Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas‐ resistant adult T‐cell leukemia cell lines , 2000, European journal of haematology.
[293] B. Evers,et al. The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies , 1999 .
[294] T. Grune,et al. Proteolysis, caloric restriction and aging , 2001, Mechanisms of Ageing and Development.
[295] James Lowe,et al. Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.
[296] M. Runge,et al. Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[297] P. Cresswell,et al. MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding , 1994, Nature.
[298] H. Yokosawa,et al. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability. , 2000, European journal of biochemistry.
[299] K. Tanaka,et al. A novel DNA vaccine based on ubiquitin–proteasome pathway targeting ‘self’-antigens expressed in melanoma/melanocyte , 2005, Gene Therapy.
[300] M. Mattson. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.
[301] M. Aridor. Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases. , 2007, Advanced drug delivery reviews.
[302] P. Freemont,et al. The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.
[303] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[304] W. Dietrich,et al. Inflammatory Mechanisms after Ischemia and Stroke , 2003, Journal of neuropathology and experimental neurology.
[305] D. Pearce,et al. The neuronal ceroid lipofuscinoses , 2007, NeuroMolecular Medicine.
[306] J. Lucas,et al. Full Motor Recovery Despite Striatal Neuron Loss and Formation of Irreversible Amyloid-Like Inclusions in a Conditional Mouse Model of Huntington's Disease , 2005, The Journal of Neuroscience.
[307] A. Goldberg,et al. The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.
[308] J. Han,et al. The melanoma growth stimulatory activity receptor consists of two proteins. Ligand binding results in enhanced tyrosine phosphorylation. , 1992, Journal of immunology.
[309] L. D. De Girolamo,et al. Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson’s disease aetiology , 2008, Journal of neurochemistry.
[310] C. Rupar,et al. Rat liver lysosome membranes are enriched in alpha-tocopherol. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[311] A. Wandinger-Ness,et al. Functional analyses and interaction of the XAPC7 proteasome subunit with Rab7. , 2005, Methods in enzymology.
[312] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[313] D. Rubinsztein,et al. Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. , 2007, Experimental cell research.
[314] Kenneth C Anderson,et al. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions. , 2007, Experimental hematology.
[315] D. Turk,et al. Lysosomal cysteine proteases (cathepsins): promising drug targets. , 2003, Acta crystallographica. Section D, Biological crystallography.
[316] R. Klausner,et al. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. , 1996, Biochimica et biophysica acta.
[317] R. Wadhwa,et al. Preincubation with the Proteasome Inhibitor MG‐132 Enhances Proteasome Activity via the Nrf2 Transcription Factor in Aging Human Skin Fibroblasts , 2006, Annals of the New York Academy of Sciences.
[318] T. Reinheckel,et al. Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.
[319] P. Elliott,et al. Proteasome inhibition: a new anti-inflammatory strategy , 2003, Journal of Molecular Medicine.
[320] Y. Wan,et al. Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study. , 2001, Experimental and molecular pathology.
[321] P. Howley,et al. DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[322] R. Plemper,et al. Endoplasmic reticulum degradation. Reverse protein transport and its end in the proteasome , 1999, Molecular Biology Reports.
[323] J. Harney,et al. Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. , 2002, Molecular endocrinology.
[324] S. Carillo,et al. High plasma proteasome levels are detected in patients with metastatic malignant melanoma , 2005, The British journal of dermatology.
[325] J. Lucas,et al. The Ubiquitin-Proteasome System in Huntington’s Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[326] J. Brodsky,et al. ER protein quality control and proteasome-mediated protein degradation. , 1999, Seminars in cell & developmental biology.
[327] V. Couch,et al. von Hippel-Lindau disease. , 2000, Mayo Clinic proceedings.
[328] J. Hirrlinger,et al. Glutathione metabolism in brain , 2000 .
[329] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[330] D. Rubinsztein,et al. Decreased cAMP Response Element-mediated Transcription , 2004, Journal of Biological Chemistry.
[331] B. Friguet,et al. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. , 1996, Archives of biochemistry and biophysics.
[332] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[333] T. Saruta,et al. Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells , 1995, FEBS letters.
[334] J. Girault,et al. Phosphorylation of Arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced Toxicity by Rescuing Proteasome Impairment* , 2005, Journal of Biological Chemistry.
[335] Sunny Shin,et al. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. , 1998, Chemistry & biology.
[336] T. Mizushima,et al. The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.
[337] F. Tortella,et al. Delayed Treatment with MLN519 Reduces Infarction and Associated Neurologic Deficit Caused by Focal Ischemic Brain Injury in Rats via Antiinflammatory Mechanisms Involving Nuclear Factor-κB Activation, Gliosis, and Leukocyte Infiltration , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[338] Y. Takasaki,et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus , 1990, Clinical and experimental immunology.
[339] M. Yáñez-Mó,et al. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. , 2006, Cancer research.
[340] A. Rivett,et al. Processing of N3, a mammalian proteasome beta-type subunit. , 1996, The Biochemical journal.
[341] Brian Kuhlman,et al. E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer , 2005, Nature Structural &Molecular Biology.
[342] Boris Pfander,et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.
[343] G. Giebisch,et al. CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney. , 2006, The Journal of clinical investigation.
[344] J. Tobias,et al. Universality and structure of the N-end rule. , 1989, The Journal of biological chemistry.
[345] L. Tessitore,et al. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. , 1996, Biochemical and biophysical research communications.
[346] T. Zglinicki,et al. Lipofuscin accumulation in proliferating fibroblasts in vitro: an indicator of oxidative stress , 2001, Experimental Gerontology.
[347] K. Davies,et al. Selective degradation of oxidatively modified protein substrates by the proteasome. , 2003, Biochemical and biophysical research communications.
[348] Y. Kong,et al. E2-25K/Hip-2 regulates caspase-12 in ER stress–mediated Aβ neurotoxicity , 2008, The Journal of cell biology.
[349] B. Friguet,et al. Proteasome and Photoaging , 2007, Annals of the New York Academy of Sciences.
[350] J. Hanke. Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas , 2000, Anatomy and Embryology.
[351] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[352] M. Goedert,et al. Phosphorylation of tau by cyclic-AMP-dependent protein kinase. , 1993, Dementia.
[353] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[354] Dawn C. Bisi,et al. Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation. , 2002, Nucleic acids research.
[355] P. Thomas,et al. Endoproteolytic Activity of the Proteasome , 2002, Science.
[356] S. Wing,et al. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. , 1994, The American journal of physiology.
[357] C. Crews,et al. Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. , 2008, Chemistry & biology.
[358] A. Goldberg,et al. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. , 1997, The Journal of clinical investigation.
[359] R. Takahashi,et al. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[360] A. Goette,et al. Prevalence and pathology of amyloid in atherosclerotic arteries. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[361] N. Hattori,et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.
[362] N. Agell,et al. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. , 1998, Cancer letters.
[363] P. Flakoll,et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. , 2002, American journal of physiology. Endocrinology and metabolism.
[364] W. Baumeister,et al. AAA-ATPases at the crossroads of protein life and death , 1999, Nature Cell Biology.
[365] D. Haines,et al. WW domains 2 and 3 of Rsp5p play overlapping roles in binding to the LPKY motif of Spt23p and Mga2p. , 2008, The international journal of biochemistry & cell biology.
[366] Feras Hatahet,et al. Substrate recognition by the protein disulfide isomerases , 2007, The FEBS journal.
[367] J. Nowak,et al. Age-related macular degeneration (AMD): pathogenesis and therapy. , 2006, Pharmacological reports : PR.
[368] C. Crews,et al. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α', β'-epoxyketones , 1999 .
[369] G. Sobue. [Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)]. , 2003, Rinsho shinkeigaku = Clinical neurology.
[370] M. Glickman,et al. Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion. , 2008, Molecular biology of the cell.
[371] Y. Ishii,et al. Redox Regulation of Cell Growth and Cell Death , 2003, Biological chemistry.
[372] A Ciechanover,et al. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[373] R. Marfella,et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. , 1997, Circulation.
[374] T. Pandita,et al. Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability , 2008, Proceedings of the National Academy of Sciences.
[375] Robert B. Petersen,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[376] S. Lowe,et al. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. , 2005, Cancer research.
[377] R. Schekman,et al. Sec61p and BiP directly facilitate polypeptide translocation into the ER , 1992, Cell.
[378] Tobias Jung,et al. Age-related differences in oxidative protein-damage in young and senescent fibroblasts. , 2009, Archives of biochemistry and biophysics.
[379] D. Ferrington,et al. Altered proteasome structure, function, and oxidation in aged muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[380] J. Weiss,et al. Intrathecal infusion of a Ca2+-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS , 2007, Experimental Neurology.
[381] A. Amerik,et al. Mechanism and function of deubiquitinating enzymes. , 2004, Biochimica et biophysica acta.
[382] A. Varshavsky,et al. The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[383] A P Arrigo,et al. Gene expression and the thiol redox state. , 1999, Free radical biology & medicine.
[384] H. Schindelin,et al. The sulfurtransferase activity of Uba4 presents a link between ubiquitin-like protein conjugation and activation of sulfur carrier proteins. , 2008, Biochemistry.
[385] D. Busch,et al. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[386] E. Stadtman. Protein oxidation and aging , 2006, Science.
[387] H. Brody. The deposition of aging pigment in the human cerebral cortex. , 1960, Journal of gerontology.
[388] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[389] Yulian Wu,et al. The proteasome controls the expression of a proliferation‐associated nuclear antigen Ki‐67 , 2000, Journal of cellular biochemistry.
[390] E. Stadtman,et al. Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[391] Yong Zhang,et al. SPD—a web-based secreted protein database , 2004, Nucleic Acids Res..
[392] D. Butterfield,et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.
[393] E. Stadtman,et al. Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.
[394] E. Mandelkow,et al. Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease , 2007, Brain pathology.
[395] D.Y. Lee,et al. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes , 2006, The British journal of dermatology.
[396] Wei Guo,et al. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors , 2005, Oncogene.
[397] Khadija Iqbal,et al. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. , 1998, Archives of biochemistry and biophysics.
[398] N. Gonatas,et al. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1G93A mutation of familial amyotrophic lateral sclerosis , 2000, Journal of the Neurological Sciences.
[399] J. Stankova,et al. Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor* , 2003, Journal of Biological Chemistry.
[400] J. Lee,et al. Evidence That CD147 Modulation of β-Amyloid (Aβ) Levels Is Mediated by Extracellular Degradation of Secreted Aβ*♦ , 2008, Journal of Biological Chemistry.
[401] Jie Liang,et al. Subunit–subunit interactions in the human 26S proteasome , 2008, Proteomics.
[402] J. Ávila. Tau protein, the main component of paired helical filaments. , 2006, Journal of Alzheimer's disease : JAD.
[403] R. Ferrante,et al. Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[404] D. Phoenix,et al. Calpains: enzymes of vision? , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[405] R. Dohmen,et al. The C-terminal Extension of the β7 Subunit and Activator Complexes Stabilize Nascent 20 S Proteasomes and Promote Their Maturation* , 2007, Journal of Biological Chemistry.
[406] S. Gerstberger,et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.
[407] D. Ferrington,et al. Altered proteasome function and subunit composition in aged muscle. , 2004, Archives of biochemistry and biophysics.
[408] T. Iftner,et al. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. , 2005, Cancer research.
[409] P. Lipton,et al. Ischemic cell death in brain neurons. , 1999, Physiological reviews.
[410] T. Maniatis,et al. Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathway , 1991, Nature.
[411] K. Nakayama,et al. CHIP promotes proteasomal degradation of familial ALS‐linked mutant SOD1 by ubiquitinating Hsp/Hsc70 , 2004, Journal of neurochemistry.
[412] Ryoichi Arai,et al. Structure of human ubiquitin-conjugating enzyme E2 G2 (UBE2G2/UBC7). , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.
[413] K. Gould,et al. Structural insights into the U-box, a domain associated with multi-ubiquitination , 2003, Nature Structural Biology.
[414] Antonio Colombo,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.
[415] H. Heinsen,et al. Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.
[416] M. Moskowitz,et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.
[417] Weimin Guo,et al. Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle. , 2004, Experimental eye research.
[418] Ari Helenius,et al. Quality control in the endoplasmic reticulum , 2003, Nature Reviews Molecular Cell Biology.
[419] K. Davies,et al. Importance of the Lon Protease in Mitochondrial Maintenance and the Significance of Declining Lon in Aging , 2007, Annals of the New York Academy of Sciences.
[420] R. Plemper,et al. Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. , 1998, Molecular biology of the cell.
[421] Seung-Jae Lee. α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease? , 2003 .
[422] G. Blobel,et al. The ubiquitin‐like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer , 1997, The EMBO journal.
[423] G. Mills,et al. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling , 2002, Oncogene.
[424] Douglas B. Evans,et al. The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .
[425] J. Lucas,et al. Is the ubiquitin-proteasome system impaired in Huntington’s disease? , 2007, Cellular and Molecular Life Sciences.
[426] V. Marchesi,et al. A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[427] M. Molinari,et al. EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. , 2006, Biochemical and biophysical research communications.
[428] A. Goldberg,et al. 26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.
[429] J. Rommens,et al. Human Homologs of Ubc6p Ubiquitin-conjugating Enzyme and Phosphorylation of HsUbc6e in Response to Endoplasmic Reticulum Stress* , 2006, Journal of Biological Chemistry.
[430] Lei Guo,et al. Calreticulin in cardiac development and pathology. , 2002, Biochimica et biophysica acta.
[431] C. Masters,et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.
[432] F. Urano,et al. Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity , 2007, Neurobiology of Disease.
[433] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[434] Hans-Georg Rammensee,et al. Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.
[435] S. Alberti,et al. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. , 2004, Molecular biology of the cell.
[436] K. Chung,et al. CREB activates proteasomal degradation of DSCR1/RCAN1 , 2008, FEBS letters.
[437] N. Minato,et al. The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C* , 2001, The Journal of Biological Chemistry.
[438] J. Kuszak,et al. The ultrastructure of epithelial and fiber cells in the crystalline lens. , 1995, International review of cytology.
[439] M. Orłowski,et al. Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex , 1983, Journal of neurochemistry.
[440] D. Ferrington,et al. Catalytic site‐specific inhibition of the 20S proteasome by 4‐hydroxynonenal , 2004, FEBS letters.
[441] R. Meyn,et al. Protease inhibitors restore radiation‐induced apoptosis to Bcl‐2‐expressing lymphoma cells , 2001, International journal of cancer.
[442] P. Cresswell,et al. Proteasomes and Proteasome Activator 200 kDa (PA200) Accumulate on Chromatin in Response to Ionizing Radiation , 2007, Radiation research.
[443] Matthew R. Johnson,et al. Role of the β1 Subunit in the Function and Stability of the 20S Proteasome in the Hyperthermophilic Archaeon Pyrococcus furiosus , 2006 .
[444] Weimin Guo,et al. Ubiquitin-proteasome pathway function is required for lens cell proliferation and differentiation. , 2006, Investigative ophthalmology & visual science.
[445] A. Goldberg,et al. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. , 1987, The Journal of biological chemistry.
[446] Christian Appenzeller‐Herzog,et al. The human PDI family: versatility packed into a single fold. , 2008, Biochimica et biophysica acta.
[447] J. Agar,et al. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.
[448] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[449] M. Chesselet,et al. Apoptosis in Huntington's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[450] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[451] J. Tobias,et al. The N-end rule in bacteria. , 1991, Science.
[452] G. Burmester,et al. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). , 2008, Rheumatology.
[453] M. Norman,et al. Differential roles of ICAM‐1 and VCAM‐1 in leukocyte‐endothelial cell interactions in skin and brain of MRL/faslpr mice , 2008, Journal of leukocyte biology.
[454] P. Burcham,et al. Diminished susceptibility to proteolysis after protein modification by the lipid peroxidation product malondialdehyde: inhibitory role for crosslinked and noncrosslinked adducted proteins. , 1997, Archives of biochemistry and biophysics.
[455] Raphaël Guérois,et al. 20S proteasome assembly is orchestrated by two distinct pairs of chaperones in yeast and in mammals. , 2007, Molecular cell.
[456] D. Westaway,et al. TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity , 2006, Nature.
[457] R. Mot. Actinomycete-like proteasomes in a Gram-negative bacterium. , 2007 .
[458] A. Badros,et al. Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait. , 2005, Clinical advances in hematology & oncology : H&O.
[459] T. Grune,et al. Proteolysis of oxidised proteins and cellular senescence , 2000, Experimental Gerontology.
[460] K. Davies,et al. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II—aging of nondividing cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[461] T. Shearer,et al. Biochemical properties of lens-specific calpain Lp85. , 2006, Experimental eye research.
[462] Hiderou Yoshida,et al. A time-dependent phase shift in the mammalian unfolded protein response. , 2003, Developmental cell.
[463] F. Beaugé,et al. The effects of acetaldehyde in vitro on proteasome activities and its potential involvement after alcoholization of rats by inhalation of ethanol vapours. , 2005, Alcohol and alcoholism.
[464] N. Shimizu,et al. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. , 1999, Human gene therapy.
[465] D. Figlewicz,et al. Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.
[466] B. J. Van den Eynde,et al. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.
[467] C. Gregorio,et al. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.
[468] H. Nothwang,et al. Prosomes and their multicatalytic proteinase activity. , 1992, European journal of biochemistry.
[469] K. Davies. Degradation of oxidized proteins by the 20S proteasome. , 2001, Biochimie.
[470] G. Reifenberger,et al. Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. , 1995, The American journal of pathology.
[471] D. Yin. Studies on age pigments evolving into a new theory of biological aging. , 1995, Gerontology.
[472] Paul J Thornalley,et al. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes , 2005, Diabetologia.
[473] K. Tanaka,et al. Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. , 1998, The Biochemical journal.
[474] Maurizio Molinari,et al. EDEM Contributes to Maintenance of Protein Folding Efficiency and Secretory Capacity* , 2004, Journal of Biological Chemistry.
[475] E. Sausville,et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. , 1999, Cancer research.
[476] Jakob W. Risch,et al. Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen. , 2002, Molecular biology of the cell.
[477] F. Shang,et al. Lens fibers have a fully functional ubiquitin-proteasome pathway. , 2002, Experimental eye research.
[478] P. Cresswell,et al. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. , 1998, Immunity.
[479] P. Kloetzel,et al. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus , 1996, The Journal of experimental medicine.
[480] Keiji Tanaka,et al. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats , 1999, Molecular Biology Reports.
[481] B. Rost,et al. NMR and X-RAY structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1-UBA5-UFC1 ubiquination pathway , 2009, Journal of Structural and Functional Genomics.
[482] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[483] A. Varshavsky,et al. The degradation signal in a short-lived protein , 1989, Cell.
[484] M. Bogyo,et al. Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[485] C. Harding,et al. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. , 1995, Journal of immunology.
[486] J. Grandis,et al. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells , 2008, Molecular Cancer Therapeutics.
[487] K. Nakashima,et al. Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation , 2000, Acta Neuropathologica.
[488] W. McBride,et al. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. , 2000, International journal of radiation oncology, biology, physics.
[489] R. Sundaram,et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. , 1996, Clinical science.
[490] N. Chondrogianni,et al. Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence , 2007, Experimental Gerontology.
[491] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[492] P. Goloubinoff,et al. Chaperones and proteases , 2007, Journal of Molecular Neuroscience.
[493] Feng-Sheng Wang,et al. Flashlamp pulsed‐dye laser suppressed TGF‐β1 expression and proliferation in cultured keloid fibroblasts is mediated by MAPK pathway , 2007, Lasers in surgery and medicine.
[494] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[495] G. Sobue,et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. , 2007, Brain : a journal of neurology.
[496] E. Stadtman,et al. Methionine sulfoxide reductase in antioxidant defense. , 1999, Methods in enzymology.
[497] Randal J. Kaufman,et al. Divergent Roles of IRE1α and PERK in the Unfolded Protein Response , 2006 .
[498] J. Arribas,et al. Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. , 1996, Biochemistry.
[499] K. Ndebele,et al. 17-β-ESTRADIOL SUPPRESSES IL-2 AND IL-2 RECEPTOR , 2001 .
[500] A. Malovannaya,et al. The SRC-3/AIB1 Coactivator Is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome , 2006, Cell.
[501] A. Helenius,et al. Multiple Endoplasmic Reticulum-associated Pathways Degrade Mutant Yeast Carboxypeptidase Y in Mammalian Cells* , 2003, Journal of Biological Chemistry.
[502] J. Lieberman,et al. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. , 2001, Blood.
[503] L. Papa,et al. Persistent mitochondrial dysfunction and oxidative stress hinder neuronal cell recovery from reversible proteasome inhibition , 2008, Apoptosis.
[504] Tom A. Rapoport,et al. Distinct Ubiquitin-Ligase Complexes Define Convergent Pathways for the Degradation of ER Proteins , 2006, Cell.
[505] Kees Jalink,et al. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. , 2003, Immunity.
[506] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[507] M. Glucksman,et al. Involvement of surface cysteines in activity and multimer formation of thimet oligopeptidase. , 2003, Protein engineering.
[508] A. Brunger,et al. Structure and function of the yeast U-box-containing ubiquitin ligase Ufd2p , 2007, Proceedings of the National Academy of Sciences.
[509] C. Masters,et al. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein , 1999, Nature Structural Biology.
[510] W. Mitch,et al. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process. , 2005, The international journal of biochemistry & cell biology.
[511] J. Manfredi,et al. Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.
[512] A. Holmgren,et al. The Contributions of Protein Disulfide Isomerase and Its Homologues to Oxidative Protein Folding in the Yeast Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.
[513] U. Brunk,et al. Lipofuscin: Mechanisms of formation and increase with age , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[514] Claudia Leidhold,et al. Chaperones and Proteases—Guardians of Protein Integrity in Eukaryotic Organelles , 2007, Annals of the New York Academy of Sciences.
[515] P. Osmulski,et al. Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity. , 2003, Biochemistry.
[516] M. Vu,et al. Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells1 , 2001, The Journal of Immunology.
[517] P. Karplus,et al. Protein sulfenic acids in redox signaling. , 2004, Annual review of pharmacology and toxicology.
[518] D. Turk,et al. Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.
[519] A. Holmgren,et al. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.
[520] O. Niemelä,et al. Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. , 1998, Alcoholism, clinical and experimental research.
[521] P. Fisher,et al. Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24. , 2008, Cancer research.
[522] J. Sacchettini,et al. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[523] C. Ji,et al. UBE1DC1, an ubiquitin‐activating enzyme, activates two different ubiquitin‐like proteins , 2008, Journal of cellular biochemistry.
[524] P. Zhou,et al. Genomic organization and tissue expression of the mouse proteasome gene Lmp-7 , 1993, Immunogenetics.
[525] J. Huibregtse,et al. A Single PXY Motif Located within the Carboxyl Terminus of Spt23p and Mga2p Mediates a Physical and Functional Interaction with Ubiquitin Ligase Rsp5p* , 2004, Journal of Biological Chemistry.
[526] A. Buchberger,et al. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97 , 2008, Cellular and Molecular Life Sciences.
[527] P. Kloetzel,et al. Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.
[528] A. Cederbaum,et al. Oxidative stress, toxicology, and pharmacology of CYP2E1. , 2004, Annual review of pharmacology and toxicology.
[529] Nadinath B. Nillegoda,et al. Ydj1 Protects Nascent Protein Kinases from Degradation and Controls the Rate of Their Maturation , 2008, Molecular and Cellular Biology.
[530] Yuh-Shan Jou,et al. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. , 2006, Journal of the National Cancer Institute.
[531] T. Grune,et al. Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. , 2000, Archives of biochemistry and biophysics.
[532] N. Osna,et al. Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. , 2006, The international journal of biochemistry & cell biology.
[533] S. Rosenkranz,et al. PI3‐kinase/Akt‐dependent antiapoptotic signaling by the PDGF α receptor is negatively regulated by Src family kinases , 2006, FEBS letters.
[534] M. Kuroda,et al. Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093. , 2000, The Journal of organic chemistry.
[535] J. de Magalhães,et al. Stress‐induced premature senescence in BJ and hTERT‐BJ1 human foreskin fibroblasts , 2002, FEBS letters.
[536] F. Mach,et al. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. , 2009, Rheumatology.
[537] E. Feldman,et al. Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.
[538] Pathogenesis of Diabetic Neuropathy , 1997 .
[539] T. Kudo,et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil , 2008, Brain Research.
[540] P. Chinnery,et al. Pathogenic expansions of the SCA6 locus are associated with a common CACNA1A haplotype across the globe: founder effect or predisposing chromosome? , 2008, European Journal of Human Genetics.
[541] P. Henklein,et al. Expression and subcellular localization of mouse 20S proteasome activator complex PA28 , 1997, FEBS letters.
[542] E. Stadtman,et al. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.
[543] R. Morimoto,et al. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates , 2005, The Journal of cell biology.
[544] Amy S. Lee,et al. ER chaperones in mammalian development and human diseases , 2007, FEBS letters.
[545] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[546] J. Simon,et al. Retinyl palmitate and the blue-light-induced phototoxicity of human ocular lipofuscin. , 2001, Archives of biochemistry and biophysics.
[547] L. Dick,et al. Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin , 1996, The Journal of Biological Chemistry.
[548] A. Ciechanover,et al. The ubiquitin system. , 1998, Annual review of biochemistry.
[549] K. Moremen,et al. Energetics of Substrate Binding and Catalysis by Class 1 (Glycosylhydrolase Family 47) α-Mannosidases Involved in N-Glycan Processing and Endoplasmic Reticulum Quality Control*[boxs] , 2005, Journal of Biological Chemistry.
[550] Yan Liu,et al. Oligosaccharide Modification in the Early Secretory Pathway Directs the Selection of a Misfolded Glycoprotein for Degradation by the Proteasome* , 1999, The Journal of Biological Chemistry.
[551] L. Klotz,et al. Nitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress. , 2007, Free radical biology & medicine.
[552] Beatriz Alvarez-Castelao,et al. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain , 2006, Journal of neurochemistry.
[553] N. Chen,et al. Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway , 2007, Cellular and Molecular Neurobiology.
[554] O. Ullrich,et al. Stability of the nuclear protein turnover during cellular senescence of human fibroblasts , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[555] A. Goldberg,et al. Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. , 1987, The Journal of biological chemistry.
[556] J. Stephens,et al. Induction of SOCS-3 is insufficient to confer IRS-1 protein degradation in 3T3-L1 adipocytes. , 2006, Biochemical and biophysical research communications.
[557] Yi Sun,et al. Targeting E3 Ubiquitin Ligases for Cancer Therapy , 2003, Cancer biology & therapy.
[558] W. Markesbery,et al. Decreased levels of proteasome activity and proteasome expression in aging spinal cord , 2000, Neuroscience.
[559] V. Bours,et al. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. , 2008, Journal of tropical pediatrics.
[560] J. Ávila,et al. Tau Phosphorylation, Aggregation, and Cell Toxicity , 2006, Journal of biomedicine & biotechnology.
[561] T. Bayer,et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[562] M. Strong,et al. The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy? , 2005, Journal of neuropathology and experimental neurology.
[563] R. Levine,et al. Modulation of the hydrophobicity of glutamine synthetase by mixed‐function oxidation , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[564] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[565] M. Groll,et al. Diversity of proteasomal missions: fine tuning of the immune response , 2007, Biological chemistry.
[566] C. Slaughter,et al. PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus. , 1993, The Journal of biological chemistry.
[567] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[568] T. Grune,et al. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. , 2005, Free radical biology & medicine.
[569] Min Chen,et al. Xenobiotic‐Induced Recruitment of Autoantigens to Nuclear Proteasomes Suggests a Role for Altered Antigen Processing in Scleroderma , 2005, Annals of the New York Academy of Sciences.
[570] D. Hebert,et al. EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites , 2007, Proceedings of the National Academy of Sciences.
[571] J. Evans,et al. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis , 2008, Eye.
[572] M. Hochstrasser,et al. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[573] D. Green,et al. Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.
[574] Tilman Grune,et al. Lipofuscin: formation, distribution, and metabolic consequences. , 2007, Annals of the New York Academy of Sciences.
[575] W. Hung,et al. Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.
[576] P. Elliott,et al. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. , 2000, Journal of autoimmunity.
[577] B. Oostra,et al. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair , 2006, Neurobiology of Disease.
[578] K. Davies,et al. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. , 2006, The Biochemical journal.
[579] M. Hochstrasser,et al. Autocatalytic Subunit Processing Couples Active Site Formation in the 20S Proteasome to Completion of Assembly , 1996, Cell.
[580] C. Olanow,et al. Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.
[581] M. Molinari,et al. Segregation and rapid turnover of EDEM1 by an autophagy-like mechanism modulates standard ERAD and folding activities. , 2008, Biochemical and biophysical research communications.
[582] U. Brunk,et al. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. , 2006, Chemico-biological interactions.
[583] Alexei F. Kisselev,et al. Processive Degradation of Proteins and Other Catalytic Properties of the Proteasome from Thermoplasma acidophilum* , 1997, The Journal of Biological Chemistry.
[584] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[585] Roberto Cappai,et al. The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .
[586] E. Bennett,et al. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. , 2005, Molecular cell.
[587] K. Xia,et al. TMP21 degradation is mediated by the ubiquitin‐proteasome pathway , 2008, The European journal of neuroscience.
[588] R. Kayed,et al. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. , 2006, The Journal of clinical investigation.
[589] Yan-chen Xie,et al. Trinucleotide expansions in the SCA7 gene in a large family with spinocerebellar ataxia and craniocervical dystonia , 2008, Neuroscience Letters.
[590] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[591] Christopher A Ross,et al. Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.
[592] C. Reilly,et al. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. , 2007, Investigative ophthalmology & visual science.
[593] C. Slaughter,et al. Primary structures of two homologous subunits of PA28, a γ‐interferon‐inducible protein activator of the 20S proteasome , 1995, FEBS letters.
[594] J. P. Jensen,et al. Expression, purification, and properties of the Ubc4/5 family of E2 enzymes. , 2005, Methods in enzymology.
[595] L. Mouthon,et al. Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes , 2006 .
[596] R. Binder,et al. Heat Shock Protein-chaperoned Peptides but Not Free Peptides Introduced into the Cytosol Are Presented Efficiently by Major Histocompatibility Complex I Molecules* , 2001, The Journal of Biological Chemistry.
[597] K. Matrougui,et al. Mice lacking the gene encoding for MMP-9 and resistance artery reactivity. , 2006, Biochemical and biophysical research communications.
[598] T. Reinheckel,et al. Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.
[599] P. Kloetzel,et al. The proteasome and MHC class I antigen processing. , 2004, Biochimica et biophysica acta.
[600] René Hen,et al. Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.
[601] R. Huber,et al. Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.
[602] K. Davies,et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[603] J. Yewdell,et al. Immunoproteasomes: regulating the regulator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[604] B. Friguet,et al. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. , 2006, Archives of biochemistry and biophysics.
[605] B. Friguet,et al. Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion* , 2001, The Journal of Biological Chemistry.
[606] B. Friguet,et al. Age-dependent declines in proteasome activity in the heart. , 2002, Archives of biochemistry and biophysics.
[607] S. Demo,et al. Drug discovery in the ubiquitin regulatory pathway. , 2003, Drug discovery today.
[608] S. W. Lin,et al. Degradation of oxidatively denatured proteins in Escherichia coli. , 1988, Free radical biology & medicine.
[609] C. Crews,et al. The ubiquitin‐proteasome pathway and proteasome inhibitors , 2001, Medicinal research reviews.
[610] A. Grover,et al. Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau , 2005, Journal of Neural Transmission.
[611] J. Arribas,et al. Proteolytic Processing and Assembly of the C5 Subunit into the Proteasome Complex* , 2000, The Journal of Biological Chemistry.
[612] E. Wiertz,et al. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. , 2006, International immunology.
[613] T. Hoppe,et al. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. , 2005, Trends in biochemical sciences.
[614] Z Chen,et al. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[615] E. Porta. Pigments in Aging: An Overview , 2002, Annals of the New York Academy of Sciences.
[616] I. Grundke‐Iqbal,et al. Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[617] M. Moskowitz,et al. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase , 1996, Neuroscience.
[618] K. Kimura,et al. Dysfunction of the ER chaperone BiP accelerates the renal tubular injury. , 2008, Biochemical and biophysical research communications.
[619] G. Kroemer. [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.
[620] A. Mogk,et al. Proteomic Analysis of Mitochondrial Protein Turnover: Identification of Novel Substrate Proteins of the Matrix Protease Pim1 , 2006, Molecular and Cellular Biology.
[621] J. Stankova,et al. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor. , 2007, Cellular signalling.
[622] M. Papotti,et al. Interferon-γ-inducible subunits are incorporated in human brain 20S proteasome , 2003, Journal of Neuroimmunology.
[623] C. Kretz-remy,et al. Gene expression and thiol redox state. , 1999, Methods in enzymology.
[624] Ulf Hellman,et al. The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases1 , 2002, The Journal of Immunology.
[625] D. Pain,et al. Mrs3p, Mrs4p, and Frataxin Provide Iron for Fe-S Cluster Synthesis in Mitochondria* , 2006, Journal of Biological Chemistry.
[626] G. Cortopassi,et al. Frataxin, iron-sulfur clusters, heme, ROS, and aging. , 2006, Antioxidants & redox signaling.
[627] C. Bartsch,et al. Long‐term up‐regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin–proteasome pathway , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[628] J. Blein,et al. Proteasome comprising a β1 inducible subunit acts as a negative regulator of NADPH oxidase during elicitation of plant defense reactions , 2005, FEBS letters.
[629] J. Newell,et al. The RING finger protein Siah‐1 regulates the level of the transcriptional coactivator OBF‐1 , 2001, The EMBO journal.
[630] M. Elleder,et al. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders , 1997, Acta Neuropathologica.
[631] A. Goldberg,et al. Selective Inhibitors of the Proteasome-dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae * , 1996, The Journal of Biological Chemistry.
[632] M. Salmona,et al. Insoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis Mice* , 2006, Journal of Biological Chemistry.
[633] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[634] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[635] P. Kloetzel,et al. The Role of the Proteasome System and the Proteasome Activator PA28 Complex in the Cellular Immune Response , 1999, Biological chemistry.
[636] R. Tampé,et al. Structure and Dynamics of Membrane-associated ICP47, a Viral Inhibitor of the MHC I Antigen-processing Machinery* , 2006, Journal of Biological Chemistry.
[637] M. Satoh,et al. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. , 1991, Cancer research.
[638] G. Plant,et al. Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.
[639] K. Tanaka,et al. Half-life of proteasomes (multiprotease complexes) in rat liver. , 1989, Biochemical and biophysical research communications.
[640] P. Elliott,et al. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. , 2002, The Journal of clinical investigation.
[641] J. Qin,et al. Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. , 2006, Biochemistry.
[642] R. Sitia,et al. Dynamic retention of Ero1α and Ero1β in the endoplasmic reticulum by interactions with PDI and ERp44 , 2006 .
[643] Keiji Tanaka,et al. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome , 2003, The EMBO journal.
[644] A. Ceriello. Postprandial hyperglycemia and diabetes complications: is it time to treat? , 2005, Diabetes.
[645] J. Neefjes,et al. MHC class I alleles and their exploration of the antigen‐processing machinery , 2005, Immunological reviews.
[646] V. Prieto,et al. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array , 2003, Journal of cutaneous pathology.
[647] S. French,et al. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. , 2006, Experimental and molecular pathology.
[648] K. Vandenbroeck,et al. Protein disulfide isomerase-mediated cell-free assembly of recombinant interleukin-12 p40 homodimers. , 2000, European journal of biochemistry.
[649] Christopher A. Ross,et al. Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization* , 2002, The Journal of Biological Chemistry.
[650] T. Casoli,et al. Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency. , 2002, Archives of gerontology and geriatrics.
[651] C. Kahn,et al. Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. , 2002, Human molecular genetics.
[652] M. Kawahara,et al. Phosphorylation of tau at serine 416 by Ca2+/calmodulin‐dependent protein kinase II in neuronal soma in brain , 2005, Journal of neurochemistry.
[653] Asif Ahmed,et al. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. , 2006, Biochemical and biophysical research communications.
[654] M. P. Miano,et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.
[655] A. Shuaib,et al. Involvement of inflammatory cytokines in central nervous system injury , 2002, Progress in Neurobiology.
[656] A Helenius,et al. Setting the standards: quality control in the secretory pathway. , 1999, Science.
[657] K. Tanaka,et al. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. , 1992, The Journal of biological chemistry.
[658] J. Schulz,et al. Mitochondrial Protein Quality Control by the Proteasome Involves Ubiquitination and the Protease Omi* , 2008, Journal of Biological Chemistry.
[659] A. Prescott,et al. Gap junctions containing alpha8-connexin (MP70) in the adult mammalian lens epithelium suggests a re-evaluation of its role in the lens. , 1999, Experimental eye research.
[660] F. López‐Soriano,et al. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome? , 2000, Medical hypotheses.
[661] M. Youdim,et al. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. , 1994, Life sciences.
[662] J. A. Thomas,et al. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. , 1999, Archives of biochemistry and biophysics.
[663] P. Howell,et al. Structural Basis for Catalysis and Inhibition ofN-Glycan Processing Class I α1,2-Mannosidases* , 2000, The Journal of Biological Chemistry.
[664] T. Mizushima,et al. New crystal forms and low resolution structure analysis of 20S proteasomes from bovine liver. , 2000, Journal of biochemistry.
[665] A. Rivett,et al. Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. , 1985, The Journal of biological chemistry.
[666] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.
[667] S. Gygi,et al. The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle , 2005, Nature Structural &Molecular Biology.
[668] J. Peters,et al. Proteasomes: protein degradation machines of the cell. , 1994, Trends in biochemical sciences.
[669] J. Andersen,et al. Does cellular iron dysregulation play a causative role in Parkinson’s disease? , 2004, Ageing Research Reviews.
[670] R. Rubenstein. Novel, mechanism-based therapies for cystic fibrosis , 2005, Current opinion in pediatrics.
[671] M. Ingelman-Sundberg,et al. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway. , 1999, Frontiers in bioscience : a journal and virtual library.
[672] N. Chondrogianni,et al. Overexpression of Proteasome β5 Assembled Subunit Increases the Amount of Proteasome and Confers Ameliorated Response to Oxidative Stress and Higher Survival Rates*[boxs] , 2005, Journal of Biological Chemistry.
[673] M. Mattson,et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.
[674] D. Nowis,et al. Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates. , 2006, Experimental cell research.
[675] M. Glickman,et al. Yeast Antizyme Mediates Degradation of Yeast Ornithine Decarboxylase by Yeast but Not by Mammalian Proteasome , 2008, Journal of Biological Chemistry.
[676] C. Reilly,et al. Transformation of the proteasome with age‐related macular degeneration , 2007, FEBS letters.
[677] Keiji Tanaka,et al. Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells , 1998 .
[678] T. Mizushima,et al. Structure determination of the constitutive 20S proteasome from bovine liver at 2.75 A resolution. , 2002, Journal of biochemistry.
[679] Bart Barlogie,et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. , 2003, The New England journal of medicine.
[680] C. Warren Olanow,et al. Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.
[681] M. Orłowski,et al. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. , 2000, Archives of biochemistry and biophysics.
[682] Y. Kagawa,et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.
[683] H. Ploegh,et al. Mechanisms, biology and inhibitors of deubiquitinating enzymes. , 2007, Nature chemical biology.
[684] A. Ciechanover,et al. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. , 2004, Cardiovascular research.
[685] M. Nakanishi,et al. A degradation signal located in the C‐terminus of p21WAF1/CIP1 is a binding site for the C8 α‐subunit of the 20S proteasome , 2001, The EMBO journal.
[686] F. Menzies,et al. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[687] Hans-Georg Rammensee,et al. Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.
[688] A. Holmgren,et al. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. , 1994, The Journal of biological chemistry.
[689] J. Sosman,et al. Molecular Targets in Melanoma from Angiogenesis to Apoptosis , 2006, Clinical Cancer Research.
[690] T. McDonnell,et al. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53 , 1998, Oncogene.
[691] C. Fan,et al. Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator , 2006, Cell.
[692] M. Tisdale,et al. Mechanism of muscle protein degradation induced by a cancer cachectic factor. , 1998, British Journal of Cancer.
[693] A. Tomkinson,et al. The N-degron protein degradation strategy for investigating the function of essential genes: requirement for replication protein A and proliferating cell nuclear antigen proteins for nucleotide excision repair in yeast extracts. , 1998, Mutation research.
[694] N. Munshi,et al. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. , 2002, Blood.
[695] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[696] K. Rock,et al. Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.
[697] T. Nakamura,et al. An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[698] T. Kurz. Can lipofuscin accumulation be prevented? , 2008, Rejuvenation research.
[699] T. Elliott,et al. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport , 1995, European journal of immunology.
[700] B. Friguet,et al. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. , 2006, Antioxidants & redox signaling.
[701] A. Goldberg,et al. The Internal Sequence of the Peptide-Substrate Determines Its N-Terminus Trimming by ERAP1 , 2008, PloS one.
[702] U. Brunk,et al. Testing the “garbage” accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy , 2004, Biogerontology.
[703] M. McMahon,et al. Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival , 2008, Pigment cell & melanoma research.
[704] P. T. Englund,et al. Identification of a Bacterial-Like HslVU Protease in the Mitochondria of Trypanosoma brucei and Its Role in Mitochondrial DNA Replication , 2008, PLoS pathogens.
[705] Toshiharu Suzuki,et al. Endoplasmic reticulum chaperones inhibit the production of amyloid-β peptides , 2007 .
[706] J. Sjöstrand,et al. Decreased caspase-3 activity in human lens epithelium from posterior subcapsular cataracts. , 2003, Experimental eye research.
[707] E. Stadtman,et al. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[708] F. Latif,et al. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. , 1995, Oncogene.
[709] P. Kloetzel,et al. Antitopes Define Preferential Proteasomal Cleavage Site Usage* , 2008, Journal of Biological Chemistry.
[710] A. Goldberg,et al. Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.
[711] D. Rubinsztein,et al. Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.
[712] D. Finley,et al. A Ubiquitin Stress Response Induces Altered Proteasome Composition , 2007, Cell.
[713] M. Portero-Otín,et al. Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney. , 1999, Diabetes.
[714] B. Walker,et al. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals). , 1998, Bioorganic & medicinal chemistry letters.
[715] B. Friguet,et al. Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. , 2002, Free radical biology & medicine.
[716] A. Goldberg,et al. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes , 2002, The EMBO journal.
[717] A. Babour,et al. Two Hrd1p homologues in the yeast Yarrowia lipolytica which act in different pathways , 2006, Molecular Genetics and Genomics.
[718] T. Reinheckel,et al. Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[719] J. Milbrandt,et al. Ionizing Radiation Down-regulates p53 Protein in Primary Egr-1−/− Mouse Embryonic Fibroblast Cells Causing Enhanced Resistance to Apoptosis* , 2001, The Journal of Biological Chemistry.
[720] S. Holland,et al. Defects in the interferon‐γ and interleukin‐12 pathways , 2005, Immunological reviews.
[721] Jianping Liu,et al. Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1 , 2005, Molecular Biology Reports.
[722] M. Hochstrasser. SP-RING for SUMO New Functions Bloom for a Ubiquitin-like Protein , 2001, Cell.
[723] J. Song,et al. Chaperone-like activity of protein disulfide-isomerase in the refolding of rhodanese. , 1995, European journal of biochemistry.
[724] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[725] A. Fukamizu,et al. Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase. , 2008, International journal of molecular medicine.
[726] M. Wride,et al. Minireview: Apoptosis as seen through a lens , 2000, Apoptosis.
[727] R. McCarron,et al. Induction of Mucosal Tolerance to E-Selectin Prevents Ischemic and Hemorrhagic Stroke in Spontaneously Hypertensive Genetically Stroke-Prone Rats , 2002, Stroke.
[728] F. Groenendaal,et al. A Dual Role of the NF-&kgr;B Pathway in Neonatal Hypoxic-Ischemic Brain Damage , 2008, Stroke.
[729] Marian Orlowski,et al. Bovine Spleen Multicatalytic Proteinase Complex (Proteasome) , 1997, The Journal of Biological Chemistry.
[730] S. Wagner,et al. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression , 2003, Melanoma research.
[731] T. Grune,et al. Protein oxidation and proteolysis in RAW264.7 macrophages: effects of PMA activation. , 2001, Biochimica et biophysica acta.
[732] B. Schulman,et al. Expression, purification, and characterization of the E1 for human NEDD8, the heterodimeric APPBP1-UBA3 complex. , 2005, Methods in enzymology.
[733] D. Wolf,et al. Ubiquitin receptors and ERAD: a network of pathways to the proteasome. , 2007, Seminars in cell & developmental biology.
[734] Jack Iwanczyk,et al. Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes. , 2006, Journal of molecular biology.
[735] R. Youle,et al. Instability of the Mitofusin Fzo1 Regulates Mitochondrial Morphology during the Mating Response of the Yeast Saccharomyces cerevisiae* , 2005, Journal of Biological Chemistry.
[736] R. Pazdur,et al. United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy , 2006, Clinical Cancer Research.
[737] L. Ellerby,et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78 , 2002, FEBS letters.
[738] E. Tani,et al. Proteasome inhibitors induce Fas‐mediated apoptosis by c‐Myc accumulation and subsequent induction of FasL message in human glioma cells , 2001, FEBS letters.
[739] S. W. Lin,et al. Oxidatively denatured proteins are degraded by an ATP-independent proteolytic pathway in Escherichia coli. , 1988, Free radical biology & medicine.
[740] L. Juliano,et al. A structure‐based site‐directed mutagenesis study on the neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) catalysis , 2003, FEBS letters.
[741] J. White,et al. Ceroid accumulation in a patient with progressive neurological disease. , 1968, Pediatrics.
[742] A. Zhitkovich,et al. Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. , 1999, Mutation research.
[743] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[744] P. J. Elliot,et al. Delayed Treatment of Ischemia/Reperfusion Brain Injury: Extended Therapeutic Window with the Proteosome Inhibitor MLN519 , 2004, Stroke.
[745] P. Hasselgren,et al. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.
[746] K. Fiebig,et al. Backbone NMR Assignment of the Human E2 Ubiquitin Conjugating Enzyme UbcH5α (F72K,F82S) Double Mutant , 2005, Journal of Biomolecular NMR.
[747] R. Vázquez-Manrique,et al. Frataxin interacts functionally with mitochondrial electron transport chain proteins. , 2005, Human molecular genetics.
[748] A. van Dorsselaer,et al. Regeneration of Peroxiredoxins during Recovery after Oxidative Stress , 2003, Journal of Biological Chemistry.
[749] Ze'ev Ronai,et al. Role of redox potential and reactive oxygen species in stress signaling , 1999, Oncogene.
[750] A. Goldberg,et al. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. , 1990, The Journal of biological chemistry.
[751] P. Kloetzel,et al. Tumor cell lines expressing the proteasome subunit isoform LMP7E1 exhibit immunoproteasome deficiency. , 2006, Cancer research.
[752] R. Tampé,et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[753] J. Qin,et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.
[754] V. Bertholet,et al. Comparison of replicative senescence and stress‐induced premature senescence combining differential display and low‐density DNA arrays , 2005, FEBS letters.
[755] G. Dawson,et al. Batten's disease: Clues to neuronal protein catabolism in lysosomes , 2000, Journal of neuroscience research.
[756] E. Gravallese,et al. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. , 1995, Arthritis and rheumatism.
[757] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[758] D. Cyr. Arrest of CFTRΔF508 folding , 2005, Nature Structural &Molecular Biology.
[759] U. Brunk,et al. Is aging the price for memory? , 2005, Biogerontology.
[760] L. Kuehn,et al. Proteasome activator PA28 and its interaction with 20 S proteasomes. , 1996, Archives of biochemistry and biophysics.
[761] T. Casoli,et al. Morphometric investigations of the mitochondrial damage in ceroid lipopigment accumulation due to vitamin E deficiency. , 2002, Archives of gerontology and geriatrics.
[762] J. Tyedmers,et al. The Sec61p complex is a dynamic precursor activated channel. , 2003, Molecular cell.
[763] U. Brunk,et al. Lysosomes and oxidative stress in aging and apoptosis. , 2008, Biochimica et biophysica acta.
[764] J. Cummings,et al. Huntington's disease. , 1997, The Psychiatric clinics of North America.
[765] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[766] P. Jenner,et al. Oxidative stress in Parkinson's disease , 2003, Annals of neurology.
[767] C. Kieling,et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) , 2008, European journal of neurology.
[768] K. Double,et al. The comparative biology of neuromelanin and lipofuscin in the human brain , 2008, Cellular and Molecular Life Sciences.
[769] P. Kloetzel,et al. The components of the proteasome system and their role in MHC class I antigen processing. , 2003, Reviews of physiology, biochemistry and pharmacology.
[770] K. Arai,et al. Altered Heart Rate Control in Response to Postural Change in Patients with Machado–Joseph Disease (SCA3) , 2009, The Cerebellum.
[771] C. Borner,et al. Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice. , 1999, Melanoma research.
[772] D. Thomas,et al. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. , 1999, Chemistry & biology.
[773] B. Carter,et al. TRAF6‐mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor , 2005, The EMBO journal.
[774] A. Hunter,et al. Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complex , 2001, Leukemia.
[775] R. Austin,et al. Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[776] D. Kraut,et al. To degrade or release: ubiquitin-chain remodeling. , 2007, Trends in cell biology.
[777] K. Nakayama,et al. Interaction of U‐box‐type ubiquitin‐protein ligases (E3s) with molecular chaperones , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[778] J L Benovic,et al. Role of Clathrin-mediated Endocytosis in Agonist-induced Down-regulation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.
[779] Sung Goo Park,et al. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes. , 2004, Biochemical and biophysical research communications.
[780] S. Bassnett,et al. Chromatin Degradation in Differentiating Fiber Cells of the Eye Lens , 1997, The Journal of cell biology.
[781] P. Elliott,et al. Early clinical experience with the novel proteasome inhibitor PS-519. , 2002, British journal of clinical pharmacology.
[782] C. McCulloch,et al. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. , 2006, Frontiers in bioscience : a journal and virtual library.
[783] K. Wang,et al. Calpain inhibition: an overview of its therapeutic potential. , 1994, Trends in pharmacological sciences.
[784] A. Goldberg,et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. , 2003, Immunity.
[785] Michael J. Ellison,et al. Cdc34 Self-Association Is Facilitated by Ubiquitin Thiolester Formation and Is Required for Its Catalytic Activity , 2003, Molecular and Cellular Biology.
[786] S. Akira,et al. Integral role of Noxa in p53-mediated apoptotic response. , 2003, Genes & development.
[787] Naoyuki Taniguchi,et al. Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity* , 2002, The Journal of Biological Chemistry.
[788] Yuichi Makino,et al. Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway* , 1999, The Journal of Biological Chemistry.
[789] Y. Nomura,et al. Novel functions of ubiquitin ligase HRD1 with transmembrane and proline-rich domains. , 2008, Journal of pharmacological sciences.
[790] T. Cotter,et al. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. , 2004, Biochimica et biophysica acta.
[791] R. Nitsch,et al. Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.
[792] J. Lowe,et al. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins , 1996, Neuroscience Letters.
[793] D. Wolf,et al. Mutants of the deubiquitinating enzyme Ubp14 decipher pathway diversity of ubiquitin-proteasome linked protein degradation. , 2006, Biochemical and biophysical research communications.
[794] R. Morimoto,et al. Heat Shock Response and Protein Degradation: Regulation of HSF2 by the Ubiquitin-Proteasome Pathway , 1998, Molecular and Cellular Biology.
[795] P. Price,et al. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. , 2006, The Journal of antimicrobial chemotherapy.
[796] D. Cyr,et al. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation , 2000, Nature Cell Biology.
[797] Ronald Wetzel,et al. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.
[798] K. Wilkinson. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. , 2000, Seminars in cell & developmental biology.
[799] B. Friguet,et al. Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. , 2005, Biochimica et biophysica acta.
[800] Keiji Tanaka,et al. Thymoproteasome: probable role in generating positively selecting peptides. , 2008, Current opinion in immunology.
[801] B. Friguet,et al. Methionine Sulfoxide Reductases , 2006, Annals of the New York Academy of Sciences.
[802] T. Shearer,et al. Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats , 2001, Current eye research.
[803] M. Pandolfo,et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.
[804] T. Lüscher,et al. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. , 1990, Hypertension.
[805] U. Andley,et al. Ubiquitin-activating enzyme (E1) isoforms in lens epithelial cells: origin of translation, E2 specificity and cellular localization determined with novel site-specific antibodies. , 2001, Experimental eye research.
[806] R. Huber,et al. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.
[807] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[808] A. Milam,et al. Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). , 2004, Molecular genetics and metabolism.
[809] Q. Dou,et al. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[810] D. Glass,et al. Molecular mechanisms modulating muscle mass. , 2003, Trends in molecular medicine.
[811] A. Bachmair,et al. PRT1 of Arabidopsis thaliana encodes a component of the plant N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[812] R. Tampé,et al. Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP , 2008, PLoS pathogens.
[813] K. Davies,et al. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells , 2001, Cellular and Molecular Life Sciences CMLS.
[814] V. Soldatenkov,et al. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. , 1997, Cancer research.
[815] M. Glickman,et al. Proteasome cerevisiae Saccharomyces The Regulatory Particle of the , 1997 .
[816] A. Goldberg,et al. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. , 1999, The Journal of clinical investigation.
[817] Tobias Jung,et al. Distribution of oxidized and HNE‐modified proteins in U87 cells , 2005, BioFactors.
[818] J. Brodsky,et al. Molecular Chaperones in the Yeast Endoplasmic Reticulum Maintain the Solubility of Proteins for Retrotranslocation and Degradation , 2001, The Journal of cell biology.
[819] L. Szweda,et al. Aging: A shift from redox regulation to oxidative damage , 2006, Free radical research.
[820] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[821] M. Moskowitz,et al. Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.
[822] A. Bachmair,et al. Arabidopsis thaliana RAD6 homolog AtUBC2 complements UV sensitivity, but not N-end rule degradation deficiency, of Saccharomyces cerevisiae rad6 mutants , 1997, Current Genetics.
[823] S. Aaronson,et al. BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage , 2004, Molecular and Cellular Biology.
[824] A. Likidlilid,et al. Glutathione and glutathione peroxidase in type 1 diabetic patients. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[825] Jianhua Liu,et al. The N-degron approach to create temperature-sensitive mutants in Schizosaccharomyces pombe. , 2004, Methods.
[826] C. Grant,et al. Non‐reciprocal regulation of the redox state of the glutathione–glutaredoxin and thioredoxin systems , 2003, EMBO reports.
[827] S. Salman,et al. Oxidative protein damage in early stage Type 1 diabetic patients. , 2000, Diabetes research and clinical practice.
[828] E. Mandelkow,et al. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. , 2008, Biochemistry.
[829] Hisashi Ito,et al. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. , 1996, Journal of biochemistry.
[830] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[831] D. Hou,et al. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. , 2007, Free radical biology & medicine.
[832] P. Zeitlin,et al. Induction of HSP70 promotes ΔF508 CFTR trafficking , 2001 .
[833] U. Schumacher,et al. The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells. , 2007, Anticancer research.
[834] R. Herbst,et al. The proteasome inhibitor PS-341 in cancer therapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[835] M. Hendrix,et al. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. , 2005, Cancer research.
[836] Z. Ronai,et al. Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis , 2000, Oncogene.
[837] Tobias Jung,et al. Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. , 2006, Free radical biology & medicine.
[838] R. Bhisitkul,et al. Iron homeostasis and toxicity in retinal degeneration , 2007, Progress in Retinal and Eye Research.
[839] J. Brodsky,et al. Recognition and delivery of ERAD substrates to the proteasome and alternative paths for cell survival. , 2005, Current topics in microbiology and immunology.
[840] Eunkyung Kim,et al. Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules. , 2005, Biochemical and biophysical research communications.
[841] M. Hayden,et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.
[842] Yifan Cheng,et al. Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.
[843] J. Holstege,et al. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.
[844] K. Tanaka,et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.
[845] G. Goldstein,et al. Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man , 1975, Nature.
[846] P. Stambrook,et al. Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. , 2001, Molecular biology of the cell.
[847] P. Kloetzel,et al. Structure and structure formation of the 20S proteasome , 1997, Molecular Biology Reports.
[848] C. Hill,et al. Structure of the proteasome activator REGα (PA28α) , 1997, Nature.
[849] O. Kaminuma,et al. Transcriptional regulation of IL-5 gene by nontransformed human T cells through the proximal promoter element. , 2000, Internal medicine.
[850] D. Green,et al. A ‘non-canonical’ DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc , 2000, Current Biology.
[851] D. Lockhart,et al. Mitotic misregulation and human aging. , 2000, Science.
[852] P. Kloetzel,et al. Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.
[853] A. Goldberg,et al. Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.
[854] M. Kikuchi,et al. Interactions among Yeast Protein-Disulfide Isomerase Proteins and Endoplasmic Reticulum Chaperone Proteins Influence Their Activities* , 2005, Journal of Biological Chemistry.
[855] B. Barlogie,et al. Extended follow‐up of a phase II trial in relapsed, refractory multiple myeloma: , 2006, Cancer.
[856] T. Siddique,et al. Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[857] Tohru Natsume,et al. A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes , 2005, Nature.
[858] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[859] H. Katinger,et al. Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome. , 2005, The Biochemical journal.
[860] J. Tainer,et al. Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. , 2002, Journal of molecular biology.
[861] Takashi Uehara,et al. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin , 2006, Journal of neurochemistry.
[862] F. Checler,et al. Proteasome Inhibitors Prevent the Degradation of Familial Alzheimer ' s Disease-Linked Presenilin 1 and Potentiate A 1342 Recovery from Human Cells , 2007 .
[863] K. Schulze-Osthoff,et al. Irradiation-induced Translocation of p53 to Mitochondria in the Absence of Apoptosis* , 2005, Journal of Biological Chemistry.
[864] Y. Ye,et al. The Viral E3 Ubiquitin Ligase mK3 Uses the Derlin/p97 Endoplasmic Reticulum-associated Degradation Pathway to Mediate Down-regulation of Major Histocompatibility Complex Class I Proteins* , 2006, Journal of Biological Chemistry.
[865] S. Oddo,et al. The ubiquitin-proteasome system in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.
[866] H. Chapman,et al. Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.
[867] R. Plemper,et al. Genetic interactions of Hrd3p and Der3p/Hrd1p with Sec61p suggest a retro-translocation complex mediating protein transport for ER degradation. , 1999, Journal of cell science.
[868] Y. Ono,et al. Phosphorylation of Tau Is Regulated by PKN* , 2001, The Journal of Biological Chemistry.
[869] W. Markesbery,et al. Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.
[870] Leland Hartwell,et al. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.
[871] J. Riordan,et al. Non-conventional Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator through the Early Secretory Pathway* , 2002, The Journal of Biological Chemistry.
[872] H. Ploegh,et al. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[873] C. Slaughter,et al. PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. , 1994, The Journal of biological chemistry.
[874] J. Marshall,et al. Age-related maculopathy and the impact of blue light hazard. , 2006, Acta ophthalmologica Scandinavica.
[875] C. Cotman,et al. Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology , 1997, Journal of neuropathology and experimental neurology.
[876] O. Niemelä,et al. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. , 2000, Journal of hepatology.
[877] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[878] W. Mitch,et al. Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.
[879] K. Davies,et al. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.
[880] S. Tsuji. Dentatorubral-pallidoluysian atrophy (DRPLA). , 2020, Journal of neural transmission. Supplementum.
[881] W. McBride,et al. The Proteasome in Cancer Biology and Treatment , 2001, Radiation research.
[882] I. Wada,et al. EDEM As an Acceptor of Terminally Misfolded Glycoproteins Released from Calnexin , 2003, Science.
[883] D. Moore. Parkin: a multifaceted ubiquitin ligase. , 2006, Biochemical Society transactions.
[884] J. Geatrell,et al. Proteases in eye development and disease. , 2006, Birth defects research. Part C, Embryo today : reviews.
[885] J. Davey,et al. Endoplasmic reticulum-associated protein degradation. , 2000, Seminars in Cell and Developmental Biology.
[886] M. Tisdale. Wasting in cancer. , 1999, The Journal of nutrition.
[887] Jeffrey L Brodsky,et al. The Recognition and Retrotranslocation of Misfolded Proteins from the Endoplasmic Reticulum , 2008, Traffic.
[888] K. Davies,et al. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. , 2005, Free radical biology & medicine.
[889] P. Ferranti,et al. Alteration in the ubiquitin structure and function in the human lens: a possible mechanism of senile cataractogenesis , 2002, FEBS letters.
[890] W. Baumeister,et al. Active Site-directed Inhibitors of Rhodococcus 20 S Proteasome , 1997, The Journal of Biological Chemistry.
[891] B. Friguet,et al. Proteolysis, free radicals, and aging. , 2002, Free radical biology & medicine.
[892] Minoru Funakoshi,et al. A multimeric assembly factor controls the formation of alternative 20S proteasomes , 2008, Nature Structural &Molecular Biology.
[893] Bertrand Friguet,et al. Impact of ageing on proteasome structure and function in human lymphocytes. , 2003, The international journal of biochemistry & cell biology.
[894] P. Fürst,et al. Proteasome- and p38-dependent Regulation of ERK3 Expression* , 2001, The Journal of Biological Chemistry.
[895] F. Shang,et al. Ubiquitin-dependent pathway is up-regulated in differentiating lens cells. , 1999, Experimental eye research.
[896] Kai Du,et al. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. , 2005, The Journal of clinical investigation.
[897] S. Ganesan,et al. Mutant SOD1 detoxification mechanisms in intact single cells , 2008, Cell Death and Differentiation.
[898] W. Reith,et al. Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[899] D. Wolf,et al. The Active Sites of the Eukaryotic 20 S Proteasome and Their Involvement in Subunit Precursor Processing* , 1997, The Journal of Biological Chemistry.
[900] K Tanaka,et al. Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.
[901] F. Luciani,et al. A mathematical model of protein degradation by the proteasome. , 2005, Biophysical journal.
[902] A. Ciechanover,et al. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes , 1995, Molecular and cellular biology.
[903] E. Feldman,et al. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. , 1999, European journal of pharmacology.
[904] Wen-Lang Lin,et al. Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.
[905] V. Gladyshev,et al. Methionine Sulfoxide Reduction and the Aging Process , 2007, Annals of the New York Academy of Sciences.
[906] S. Matalon,et al. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. , 2006, Free radical biology & medicine.
[907] G. Tiao,et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. , 1994, The Journal of clinical investigation.
[908] C. Marsden,et al. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.
[909] G. Tiao,et al. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. , 1998, The American journal of physiology.
[910] K. Thennarasu,et al. Spinocerebellar ataxias types 1, 2 and 3: Age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths , 2009, Journal of the Neurological Sciences.
[911] N. Shibata,et al. Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene , 2005, Acta Neuropathologica.
[912] John S. Mattick,et al. The Ras Target AF-6 is a Substrate of the Fam Deubiquitinating Enzyme , 1998, The Journal of cell biology.
[913] P. A. Peterson,et al. In Vivo Characterization of the Proteasome Regulator PA28* , 1996, The Journal of Biological Chemistry.
[914] S. Skatchkov,et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. , 2009, DNA repair.
[915] A H Schapira,et al. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse , 2000, Annals of neurology.
[916] P. D'Arpa,et al. Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin* , 1997, The Journal of Biological Chemistry.
[917] J. Estrela,et al. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. , 1994, Cancer research.
[918] C. Haass,et al. Endoplasmic reticulum retention of the γ‐secretase complex component Pen2 by Rer1 , 2007 .
[919] Soyeon Park,et al. Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. , 2007, Molecular cell.
[920] E. Stadtman,et al. Oxidation of Methionine in Proteins: Roles in Antioxidant Defense and Cellular Regulation , 2000, IUBMB life.
[921] R. Aebersold,et al. Proteomics Analysis of Cellular Response to Oxidative Stress , 2002, The Journal of Biological Chemistry.
[922] C. Broeckhoven,et al. Alzheimer's Disease Associated Presenilin 1 Interacts with HC5 and ZETA, Subunits of the Catalytic 20S Proteasome , 1999, Neurobiology of Disease.
[923] C. Slaughter,et al. A Model for the Quaternary Structure of the Proteasome Activator PA28* , 1996, The Journal of Biological Chemistry.
[924] C. Crews,et al. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[925] H. Ploegh,et al. SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER , 2006, The Journal of cell biology.
[926] D. Phoenix,et al. Calpains: targets of cataract prevention? , 2004, Trends in molecular medicine.
[927] P. Kloetzel,et al. A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms , 2006, Biological chemistry.
[928] V. Medici,et al. M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. , 2007, Experimental and molecular pathology.
[929] U. Brunk,et al. Autophagy, organelles and ageing , 2007, The Journal of pathology.
[930] T. Zglinicki,et al. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. , 2000, Free radical biology & medicine.
[931] V. Baracos,et al. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. , 1989, The American journal of physiology.
[932] Aaron Ciechanover,et al. The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.
[933] C. Rodighiero,et al. Protein Disulfide Isomerase Acts as a Redox-Dependent Chaperone to Unfold Cholera Toxin , 2001, Cell.
[934] D. Taillandier,et al. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia , 1999, Molecular Biology Reports.
[935] A. Boulares,et al. Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. , 2008, Cellular signalling.
[936] C. Borchers,et al. Regulation of the Cytoplasmic Quality Control Protein Degradation Pathway by BAG2* , 2005, Journal of Biological Chemistry.
[937] B. Ruebner,et al. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol‐induced liver disease , 1995, Hepatology.
[938] Donna D. Zhang. Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.
[939] D. Esseltine,et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma , 2004, British journal of haematology.
[940] G. Cagney,et al. Proteasome involvement in the repair of DNA double-strand breaks. , 2004, Molecular cell.
[941] C. Slaughter,et al. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.
[942] W. Baumeister,et al. Expression of functional Thermoplasma acidophilum proteasomes in Escherichia coli , 1992, FEBS letters.
[943] P. Riederer,et al. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.
[944] G. Semenza,et al. HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.
[945] C. Broeckhoven,et al. Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult‐onset patient with progressive visual impairments in comparison with an adult‐onset patient without visual impairments , 2008, Neuropathology and applied neurobiology.
[946] T. Rapoport,et al. The ER‐associated degradation component Der1p and its homolog Dfm1p are contained in complexes with distinct cofactors of the ATPase Cdc48p , 2008, FEBS letters.
[947] D. Finley,et al. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.
[948] James Rader,et al. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[949] Miao Zhang,et al. Proteasome-Dependent Degradation of Guanosine 5-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus , 2007, Circulation.
[950] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[951] C. Lo,et al. Connexins and cell signaling in development and disease. , 2004, Annual review of cell and developmental biology.
[952] Michael S. Wolfe,et al. Presenilin: Running with Scissors in the Membrane , 2007, Cell.
[953] T. Ogihara,et al. Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model , 1999, Gene Therapy.
[954] S. Korsmeyer,et al. Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. , 1999, Cold Spring Harbor symposia on quantitative biology.
[955] C. Fletcher,et al. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease , 2002, Nature Genetics.
[956] Maurizio Molinari,et al. A Novel Stress-induced EDEM Variant Regulating Endoplasmic Reticulum-associated Glycoprotein Degradation* , 2005, Journal of Biological Chemistry.
[957] A. Tiwari,et al. Familial Amyotrophic Lateral Sclerosis Mutants of Copper/Zinc Superoxide Dismutase Are Susceptible to Disulfide Reduction* , 2003, The Journal of Biological Chemistry.
[958] G. Lozano,et al. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.
[959] K. Nakayama,et al. U‐box protein carboxyl terminus of Hsc70‐interacting protein (CHIP) mediates poly‐ubiquitylation preferentially on four‐repeat Tau and is involved in neurodegeneration of tauopathy , 2004, Journal of neurochemistry.
[960] H. Drexler. Activation of the cell death program by inhibition of proteasome function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[961] M. Figueiredo-Pereira,et al. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. , 2004, Biochemical and biophysical research communications.
[962] R. Tiozzo,et al. Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages , 2003, Proteomics.
[963] R. Wojcikiewicz,et al. Involvement of the p97-Ufd1-Npl4 Complex in the Regulated Endoplasmic Reticulum-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors* , 2005, Journal of Biological Chemistry.
[964] N. Chondrogianni,et al. Proteasome dysfunction in mammalian aging: Steps and factors involved , 2005, Experimental Gerontology.
[965] S. Ikehara,et al. Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line. , 2001, Oncology reports.
[966] V. Chau,et al. Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.
[967] Martin Scheffner,et al. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. , 2003, Seminars in cancer biology.
[968] Tom Maniatis,et al. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.
[969] Barry Halliwell,et al. Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.
[970] M. Wick,et al. A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation , 1998 .
[971] A. Dancis,et al. Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. , 2007, Free radical biology & medicine.
[972] J. Lucas,et al. Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtin , 2009, Neurotoxicity Research.
[973] N. Osna,et al. Implication of altered proteasome function in alcoholic liver injury. , 2007, World journal of gastroenterology.
[974] T. A. Griffin,et al. Protein-protein interactions among human 20S proteasome subunits and proteassemblin. , 2004, Biochemical and biophysical research communications.
[975] R. Kopito,et al. Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.
[976] S. Varambally,et al. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition , 2007, Proceedings of the National Academy of Sciences.
[977] P. Bongioanni,et al. Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease. , 2004, The Cochrane database of systematic reviews.
[978] X. Matías-Guiu,et al. Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines , 2008, The British journal of dermatology.
[979] K. Früh,et al. Antigen presentation by MHC class I and its regulation by interferon gamma. , 1999, Current opinion in immunology.
[980] A. Steven,et al. The axial channel of the 20S proteasome opens upon binding of the PA200 activator. , 2005, Journal of molecular biology.
[981] S. Grotegut,et al. Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation. , 2006, International journal of biological macromolecules.
[982] N. Mizushima,et al. Role of the Apg12 conjugation system in mammalian autophagy. , 2003, The international journal of biochemistry & cell biology.
[983] C. Nordgaard,et al. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.
[984] A. Goldberg,et al. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.
[985] C. Rondinone,et al. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. , 2001, Diabetes.
[986] J. Dunaief. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. , 2006, Investigative ophthalmology & visual science.
[987] W. Duckworth,et al. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. , 2003, The Journal of endocrinology.
[988] P. Kloetzel,et al. Biochemical analysis of proteasomes from mouse microglia: Induction of immunoproteasomes by interferon‐γ and lipopolysaccharide , 2000, Glia.
[989] Keiji Tanaka,et al. Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis , 2007, Proceedings of the National Academy of Sciences.
[990] J. Yewdell. Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. , 2001, Trends in cell biology.
[991] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[992] A. Griswold,et al. Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila , 2008, FEBS letters.
[993] D. Ng,et al. Search and Destroy: ER Quality Control and ER-Associated Protein Degradation , 2005, Critical reviews in biochemistry and molecular biology.
[994] Jong-Bok Yoon,et al. TRIP12 functions as an E3 ubiquitin ligase of APP-BP1. , 2008, Biochemical and biophysical research communications.
[995] B. Friguet,et al. Age-dependent protein modifications and declining proteasome activity in the human lens. , 2004, Archives of biochemistry and biophysics.
[996] E. Boerwinkle,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.
[997] K D Wilkinson,et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.
[998] P. Kloetzel,et al. Immunoproteasome subunit LMP2 expression is deregulated in Sjögren’s syndrome but not in other autoimmune disorders , 2006, Annals of the rheumatic diseases.
[999] T. Rapoport,et al. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol , 2004, Nature.
[1000] H. Meyer,et al. Role(s) of Cdc48/p97 in mitosis. , 2008, Biochemical Society transactions.
[1001] E. Stadtman,et al. Oxidation of methionine residues of proteins: biological consequences. , 2003, Antioxidants & redox signaling.
[1002] Krista Fleck,et al. Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD. , 2008, Experimental cell research.
[1003] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[1004] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition , 2001 .
[1005] R. Kraft,et al. Mammalian Sec61 Is Associated with Sec62 and Sec63* , 2000, The Journal of Biological Chemistry.
[1006] Weiming Xia,et al. From presenilinase to gamma-secretase, cleave to capacitate. , 2008, Current Alzheimer research.
[1007] P. Fraser,et al. Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.
[1008] J. Hahn,et al. A stress regulatory network for co‐ordinated activation of proteasome expression mediated by yeast heat shock transcription factor , 2006, Molecular microbiology.
[1009] K. Nakayama,et al. U-box proteins as a new family of ubiquitin ligases. , 2003, Biochemical and biophysical research communications.
[1010] R. Huber,et al. Isolation and characterization of the prokaryotic proteasome homolog HslVU (ClpQY) from Thermotoga maritima and the crystal structure of HslV. , 2002, Biophysical chemistry.
[1011] R. Kopito,et al. Biosynthesis and degradation of CFTR. , 1999, Physiological reviews.
[1012] D. Waxman,et al. Termination of growth hormone pulse-induced STAT5b signaling. , 1999, Molecular endocrinology.
[1013] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[1014] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[1015] K. Sugimura,et al. Ionizing Radiation Induces a p53-dependent Apoptotic Mechanism in ARPE-19 Cells , 2004, Japanese Journal of Ophthalmology.
[1016] H. Söling,et al. The protein disulphide-isomerase family: unravelling a string of folds. , 1999, The Biochemical journal.
[1017] P. Kloetzel,et al. Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexes. , 1997, Journal of molecular biology.
[1018] T. Dawson. Parkin and defective ubiquitination in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.
[1019] A. Ciechanover,et al. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. , 1994, The Journal of biological chemistry.
[1020] C. Wójcik,et al. Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy , 2004, Stroke.
[1021] Jae Sung Hwang,et al. Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[1022] I. A. Rose,et al. Mechanism of ubiquitin carboxyl-terminal hydrolase. Borohydride and hydroxylamine inactivate in the presence of ubiquitin. , 1986, The Journal of biological chemistry.
[1023] Y. Itoyama,et al. NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1* , 2004, Journal of Biological Chemistry.
[1024] Joan E. Roberts,et al. Spectroscopic properties and reactivity of free radical forms of A2E. , 2005, Free radical biology & medicine.
[1025] J. Andersen,et al. Redox imbalance in Parkinson's disease. , 2008, Biochimica et biophysica acta.
[1026] J. Elliott,et al. Non-neuronal induction of immunoproteasome subunits in an ALS model: Possible mediation by cytokines , 2005, Experimental Neurology.
[1027] J. Schmid,et al. BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways , 2006, Clinical Cancer Research.
[1028] L. Baliko,et al. Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings , 2008, The Cerebellum.
[1029] K. Davies. Protein damage and degradation by oxygen radicals. I. general aspects. , 1987, The Journal of biological chemistry.
[1030] C. Duve. The lysosome turns fifty , 2005, Nature Cell Biology.
[1031] D. Phoenix,et al. The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017 , 2004, Molecular and Cellular Biochemistry.
[1032] Ming Yan,et al. Ube1L and Protein ISGylation Are Not Essential for Alpha/Beta Interferon Signaling , 2006, Molecular and Cellular Biology.
[1033] R. Marfella,et al. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. , 2006, Diabetes.
[1034] E A Zemskov,et al. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. , 2001, Human molecular genetics.
[1035] T. Gunatilaka,et al. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.
[1036] F. Schweisguth,et al. Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[1037] Fiona Crawford,et al. Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo , 1998, Neuroscience Letters.
[1038] JB Almond,et al. The proteasome: a novel target for cancer chemotherapy , 2002, Leukemia.
[1039] Wim J. N. Meester,et al. Small‐Molecule Inhibitors and Probes for Ubiquitin‐ and Ubiquitin‐Like‐Specific Proteases , 2005, Chembiochem : a European journal of chemical biology.
[1040] K. Hofmann,et al. Activating the ubiquitin family: UBA6 challenges the field. , 2008, Trends in biochemical sciences.
[1041] Mingsheng Zhang,et al. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin‐independent substrate , 2003, The EMBO journal.
[1042] P. Glees,et al. Lipofuscin in neuronal aging and diseases. , 1976, Normale und pathologische Anatomie.
[1043] Min Jae Lee,et al. A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons , 2005, Molecular and Cellular Biology.
[1044] R. Dohmen,et al. Role of C-terminal Extensions of Subunits β2 and β7 in Assembly and Activity of Eukaryotic Proteasomes* , 2004, Journal of Biological Chemistry.
[1045] P. Braquet,et al. The role of PAF in immunological responses: a review. , 1987, Prostaglandins.
[1046] M. Hochstrasser. Lingering Mysteries of Ubiquitin-Chain Assembly , 2006, Cell.
[1047] J. Roth,et al. Protein quality control: the who’s who, the where’s and therapeutic escapes , 2007, Histochemistry and Cell Biology.
[1048] M. Rechsteiner,et al. Molecular dissection of the 11S REG (PA28) proteasome activators. , 2001, Biochimie.
[1049] O. Isacson,et al. Generalized brain and skin proteasome inhibition in Huntington's disease , 2004, Annals of neurology.
[1050] M. Tisdale,et al. Cancer anorexia and cachexia. , 2001, Nutrition.
[1051] A. Zeiher,et al. Ubiquitin-mediated Degradation of the Proapoptotic Active Form of Bid , 2000, The Journal of Biological Chemistry.
[1052] E. Medrano,et al. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes , 2000, Experimental Gerontology.
[1053] M. Herlyn,et al. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[1054] M. Shirakawa,et al. Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition. , 2005, Structure.
[1055] Tobias Jung,et al. Oxidized proteins: intracellular distribution and recognition by the proteasome. , 2007, Archives of biochemistry and biophysics.
[1056] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[1057] N. Nukina,et al. Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. , 2006, Biochemical and biophysical research communications.
[1058] R. Galassi,et al. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. , 1994, Metabolism: clinical and experimental.
[1059] D. Louis,et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. , 1998, Molecular cell.
[1060] U. Lopes,et al. p53-dependent Induction of Apoptosis by Proteasome Inhibitors* , 1997, The Journal of Biological Chemistry.
[1061] E. Masliah,et al. alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease. , 2008, The Journal of biological chemistry.
[1062] Jean X. Jiang,et al. The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated Phosphorylation* , 2001, The Journal of Biological Chemistry.
[1063] G. Demartino,et al. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes , 2003, Journal of neurochemistry.
[1064] Wolfram Tempel,et al. Mechanism of Class 1 (Glycosylhydrolase Family 47) α-Mannosidases Involved in N-Glycan Processing and Endoplasmic Reticulum Quality Control* , 2005, Journal of Biological Chemistry.
[1065] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[1066] Rebecca A. Roberts. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins. , 2005, Drug news & perspectives.
[1067] C. Acquaviva,et al. Complex mechanisms for c-fos and c-jun degradation , 1997, Molecular Biology Reports.
[1068] B. Ponder,et al. Involvement of Brca2 in DNA repair. , 1998, Molecular cell.
[1069] M. Rechsteiner,et al. PA200, a nuclear proteasome activator involved in DNA repair , 2002, The EMBO journal.
[1070] N. Agell,et al. Muscle wasting associated with cancer cachexia is linked to an important activation of the atp‐dependent ubiquitin‐mediated proteolysis , 1995, International journal of cancer.
[1071] T. Rapoport. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes , 2007, Nature.
[1072] A. García-Sastre,et al. Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection , 2008, Journal of Virology.
[1073] E. Stadtman,et al. Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.
[1074] C. Harris,et al. Distinct pattern of p53 phosphorylation in human tumors , 2001, Oncogene.
[1075] D. Harman. Free radical theory of aging: dietary implications , 1972 .
[1076] P. Roepstorff,et al. Transcriptome and Proteome Analysis in Human Senescent Fibroblasts and Fibroblasts Undergoing Premature Senescence Induced by Repeated Sublethal Stresses , 2000, Annals of the New York Academy of Sciences.
[1077] Mingsheng Zhang,et al. Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate. , 2005, Methods in enzymology.
[1078] F. Shang,et al. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. , 1995, The Biochemical journal.
[1079] P. Elliott,et al. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer , 2001, Journal of cellular biochemistry.
[1080] U. Brunk,et al. Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis , 1998, Mechanisms of Ageing and Development.
[1081] Keiji Tanaka. The proteasome: Overview of structure and functions , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[1082] M. Ward,et al. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[1083] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[1084] J. Blumberg,et al. Regulation of Ubiquitin-conjugating Enzymes by Glutathione Following Oxidative Stress* , 1997, The Journal of Biological Chemistry.
[1085] D. Richardson,et al. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. , 2001, The international journal of biochemistry & cell biology.
[1086] R. Hampton. ER-associated degradation in protein quality control and cellular regulation. , 2002, Current opinion in cell biology.
[1087] R. Huber,et al. A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism , 2008, Nature.
[1088] Elke Krüger,et al. The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum , 2007, EMBO reports.
[1089] G. Burmester,et al. Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndrome. , 2006, Arthritis and rheumatism.
[1090] J. de Jersey,et al. Detection of stable acetaldehyde-modified proteins in the livers of ethanol-fed rats. , 1991, Alcohol and alcoholism.
[1091] M. Fortini,et al. Genetic analysis of the role of the drosophila fat facets gene in the ubiquitin pathway. , 1999, Developmental genetics.
[1092] B. Friguet,et al. Protein Degradation by the Proteasome and Its Implications in Aging , 2000, Annals of the New York Academy of Sciences.
[1093] R F Standaert,et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.
[1094] K. Kosik,et al. CHIP and HSPs interact with β-APP in a proteasome-dependent manner and influence Aβ metabolism , 2007 .
[1095] Keiji Tanaka,et al. Expression of subunits of the 19S complex and of the PA28 activator in rat skeletal muscle , 1997, Molecular Biology Reports.
[1096] M. Bogyo,et al. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[1097] D. Wolf,et al. Ubiquitin Ligase Hul5 Is Required for Fragment-specific Substrate Degradation in Endoplasmic Reticulum-associated Degradation* , 2008, Journal of Biological Chemistry.
[1098] Zekun Guo,et al. Human Aurora-B binds to a proteasome α-subunit HC8 and undergoes degradation in a proteasome-dependent manner , 2003, Molecular and Cellular Biochemistry.
[1099] K. Anderson,et al. Clinical update: novel targets in multiple myeloma. , 2004, Seminars in oncology.
[1100] T. Grune,et al. Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.
[1101] D. Schenkein. Proteasome inhibitors in the treatment of B-cell malignancies. , 2002, Clinical lymphoma.
[1102] B. Monsarrat,et al. Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation1 , 2006, The Journal of Immunology.
[1103] R. Huber,et al. Bivalency as a principle for proteasome inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[1104] S. Lovestone,et al. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells , 2001, Neuroscience.
[1105] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[1106] D. L. Coppock,et al. Generating Disulfides in Multicellular Organisms: Emerging Roles for a New Flavoprotein Family* , 2007, Journal of Biological Chemistry.
[1107] Lei Guo,et al. COUP-TF1 Antagonizes Nkx2.5-mediated Activation of the Calreticulin Gene during Cardiac Development* , 2001, The Journal of Biological Chemistry.
[1108] M. Ohira,et al. A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner , 2008, Oncogene.
[1109] A. Varshavsky,et al. Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin‐mediated proteolysis in Saccharomyces cerevisiae. , 1996, The EMBO journal.
[1110] J. Broers,et al. Detailed analysis of cell cycle kinetics upon proteasome inhibition. , 1997, Cytometry.
[1111] H. Sies,et al. Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.
[1112] I. Chantret,et al. Free-oligosaccharide control in the yeast Saccharomyces cerevisiae: roles for peptide:N-glycanase (Png1p) and vacuolar mannosidase (Ams1p). , 2003, The Biochemical journal.
[1113] A. Dancis,et al. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). , 2003, Human molecular genetics.
[1114] H. Banjar. Mortality data for cystic fibrosis patients in a tertiary care center in Saudi Arabia. , 2003, Annals of Saudi medicine.
[1115] P. Silver,et al. The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. , 2001, Molecular biology of the cell.
[1116] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[1117] K. Schwarz,et al. Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why? , 2001 .
[1118] I. Wada,et al. A novel ER α‐mannosidase‐like protein accelerates ER‐associated degradation , 2001 .
[1119] K. Davies,et al. Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis. , 1986, Journal of free radicals in biology & medicine.
[1120] Lee Sp,et al. Ceroid enteropathy and vitamin E deficiency. , 1976 .
[1121] A. Rivett,et al. Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins. , 2004, Current protein & peptide science.
[1122] G. Paolisso,et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. , 2006, Journal of the American College of Cardiology.
[1123] L. Dick,et al. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.
[1124] J. Yewdell,et al. CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.
[1125] E. Stadtman,et al. Methionine residues as endogenous antioxidants in proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[1126] K. Takahashi,et al. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities. , 2000, The Journal of antibiotics.
[1127] A. Medhurst,et al. Proteasomal activity in brain differs between species and brain regions and changes with age , 2005, Mechanisms of Ageing and Development.
[1128] Claudio Realini,et al. KEKE motifs , 1994, FEBS letters.
[1129] R. Huber,et al. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor. , 2001, Journal of molecular biology.
[1130] A. Goldberg,et al. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[1131] I. Noher de Halac,et al. Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses. , 2005, Clinical biochemistry.
[1132] J. Connor,et al. Developmental, regional, and cellular expression of SFT/UbcH5A and DMT1 mRNA in brain , 2004, Journal of neuroscience research.
[1133] J. Keller,et al. Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome? , 2006, Free radical biology & medicine.
[1134] Qingbo Xu,et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. , 1993, The American journal of pathology.
[1135] A. Luder,et al. LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[1136] B. Friguet,et al. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[1137] P. Jenner,et al. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. , 1996, Pathologie-biologie.
[1138] D. Battleman,et al. Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series. , 2008, Clinical advances in hematology & oncology : H&O.
[1139] M. Rechsteiner,et al. The Proteasome Activator 11 S Regulator or PA28 , 1998, The Journal of Biological Chemistry.
[1140] Pietro Fratta,et al. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. , 2005, The American journal of pathology.
[1141] Y. Christen,et al. Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.
[1142] D. Tuma. Role of malondialdehyde-acetaldehyde adducts in liver injury. , 2002, Free radical biology & medicine.
[1143] K. Davies,et al. Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome* , 1998, The Journal of Biological Chemistry.
[1144] Aubrey D.N.J. de Grey,et al. HO2*: the forgotten radical. , 2002 .
[1145] Keiji Tanaka,et al. Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes , 2007, Science.
[1146] D. Schmechel. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? , 2007, Neurotoxicology.
[1147] A. Cuervo,et al. Degradation of proteasomes by lysosomes in rat liver. , 1995, European journal of biochemistry.
[1148] R. Krug,et al. Properties of the ISG15 E1 enzyme UbE1L. , 2005, Methods in enzymology.
[1149] M. Ator,et al. P'-extended α-ketoamide inhibitors of proteasome , 1999 .
[1150] D. Yin,et al. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. , 1996, Free radical biology & medicine.
[1151] Christine Kim,et al. Endoplasmic Reticulum Degradation Requires Lumen to Cytosol Signaling , 2000, The Journal of cell biology.
[1152] S. Price,et al. Proteolysis, the ubiquitin-proteasome system, and renal diseases. , 2003, American journal of physiology. Renal physiology.
[1153] P. Drain,et al. Derlin-1 Promotes the Efficient Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and CFTR Folding Mutants* , 2006, Journal of Biological Chemistry.
[1154] S. Elledge,et al. How the Cyclin Became a Cyclin Regulated Proteolysis in the Cell Cycle , 1999, Cell.
[1155] M. Pariat,et al. Ubiquitinylation is not an absolute requirement for degradation of c- Jun protein by the 26 S proteasome , 1995, The Journal of Biological Chemistry.
[1156] G. Ginsburg,et al. Integrating diagnostics and therapeutics: revolutionizing drug discovery and patient care. , 2002, Drug discovery today.
[1157] T. Reinheckel,et al. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[1158] R. Huber,et al. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. , 2004, Biochimica et biophysica acta.
[1159] N. Agell,et al. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. , 1997, Biochemical and biophysical research communications.
[1160] P. Elliott,et al. Proteasome inhibition: A novel mechanism to combat asthma. , 1999, The Journal of allergy and clinical immunology.
[1161] J. Ávila,et al. Characterization of Alzheimer paired helical filaments by electron microscopy , 2005, Microscopy research and technique.
[1162] R. Tennant,et al. Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis* , 2003, The Journal of Biological Chemistry.
[1163] N. Agell,et al. Ubiquitin Gene Expression in Skeletal Muscle Is Increased by Tumor Necrosis Factor-α , 1994 .
[1164] T. D. Manna,et al. O diabetes melito na fibrose cística: uma comorbidade cada vez mais freqüente , 2008 .
[1165] D. Delia,et al. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI , 2001, British journal of haematology.
[1166] E. Barrett,et al. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. , 1992, The Journal of clinical investigation.
[1167] A. Ciechanover,et al. Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent. , 1994, The Biochemical journal.
[1168] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[1169] T. Nicotera,et al. Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.
[1170] T. Grune. Oxidative stress, aging and the proteasomal system , 2004, Biogerontology.
[1171] M. Rechsteiner,et al. Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL. , 2006, Molecular immunology.
[1172] Jesús Avila,et al. Tau phosphorylation and aggregation in Alzheimer's disease pathology , 2006, FEBS letters.
[1173] M. Mahowald,et al. Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6) , 2006, Neurology.
[1174] N. Shibata,et al. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. , 1996, Developmental neuroscience.
[1175] Isidro Ferrer,et al. Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.
[1176] Raymond J. Deshaies,et al. Mechanism of Lysine 48-Linked Ubiquitin-Chain Synthesis by the Cullin-RING Ubiquitin-Ligase Complex SCF-Cdc34 , 2005, Cell.
[1177] R. Seipelt,et al. Proteasome inhibition alters the transcription of multiple yeast genes. , 2004, Biochimica et biophysica acta.
[1178] M. Orłowski,et al. The multicatalytic proteinase complex, a major extralysosomal proteolytic system. , 1990, Biochemistry.
[1179] J. Camadro,et al. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia. , 2008, Human molecular genetics.
[1180] T. Reinheckel,et al. Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[1181] J. Rhodin,et al. In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid. , 1997, Journal of submicroscopic cytology and pathology.
[1182] George Kuriakose,et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages , 2003, Nature Cell Biology.
[1183] T. Kupper,et al. Inflammatory skin diseases, T cells, and immune surveillance. , 1999, The New England journal of medicine.
[1184] T. Zimmers,et al. Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.
[1185] A. Goldberg,et al. Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.
[1186] K. Moremen,et al. Human EDEM2, a novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. , 2005, Glycobiology.
[1187] E. Messing,et al. Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein* , 2002, The Journal of Biological Chemistry.
[1188] S. Kato,et al. A2E, a Pigment of the Lipofuscin of Retinal Pigment Epithelial Cells, Is an Endogenous Ligand for Retinoic Acid Receptor* , 2008, Journal of Biological Chemistry.
[1189] I. Komuro,et al. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases. , 2004, Current pharmaceutical design.
[1190] Jingzhi Li,et al. Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex. , 2006, The Biochemical journal.
[1191] Keiji Tanaka,et al. 4-Hydroxy-2-nonenal-mediated Impairment of Intracellular Proteolysis during Oxidative Stress , 1999, The Journal of Biological Chemistry.
[1192] S. W. Davies,et al. Filamentous nerve cell inclusions in neurodegenerative diseases , 1998, Current Opinion in Neurobiology.
[1193] G. Clawson. Protease inhibitors and carcinogenesis: a review. , 1996, Cancer investigation.
[1194] G. Pasinetti,et al. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: The role of AKT , 2004, Neuroscience.
[1195] Qing Yang,et al. Proteasome subunit LMP2 is required for matrix metalloproteinase‐2 and ‐9 expression and activities in human invasive extravillous trophoblast cell line , 2006, Journal of cellular physiology.
[1196] J. Papaconstantinou,et al. Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. , 2008, Biochemical and biophysical research communications.
[1197] G. Ailawadi,et al. Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. , 2004, The Journal of surgical research.
[1198] S. W. Lin,et al. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. , 1990, The Journal of biological chemistry.
[1199] E. Hartmann,et al. A role for mammalian Ubc6 homologues in ER-associated protein degradation. , 2002, Journal of cell science.
[1200] James B. Mitchell,et al. Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF‐κB , 2000, Head & neck.
[1201] Adrianna Skoneczna,et al. The spectrum of spontaneous mutations caused by deficiency in proteasome maturase Ump1 in Saccharomyces cerevisiae , 2007, Current Genetics.
[1202] M. Crompton. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. , 2000, Current opinion in cell biology.
[1203] E. J. Simon,et al. A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor , 2006, Brain Research.
[1204] M. Gilca,et al. The oxidative hypothesis of senescence. , 2007, Journal of postgraduate medicine.
[1205] Chunjiang Tan,et al. Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis , 2006, Clinical chemistry and laboratory medicine.
[1206] A. Terman,et al. Proteasome Inhibition Enhances Lipofuscin Formation , 2002, Annals of the New York Academy of Sciences.
[1207] S. Wolff,et al. Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose , 1990, Diabetes.
[1208] M. Chopp,et al. Postischemic (6-Hour) Treatment With Recombinant Human Tissue Plasminogen Activator and Proteasome Inhibitor PS-519 Reduces Infarction in a Rat Model of Embolic Focal Cerebral Ischemia , 2001, Stroke.
[1209] E. Mazzon,et al. Beneficial effects of Mn(III)tetrakis (4‐benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan‐induced shock , 1999, British journal of pharmacology.
[1210] K. Prasad,et al. Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment , 2002, Journal of the American College of Nutrition.
[1211] H. Ploegh,et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. , 2001, Chemistry & biology.
[1212] A. Goldberg,et al. The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. , 2001, Molecular cell.
[1213] M. Baptista,et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. , 2005, Brain : a journal of neurology.
[1214] O. Arancio,et al. Alpha-synuclein: between synaptic function and dysfunction. , 2003, Histology and histopathology.
[1215] T. Sommer,et al. Ubx2 links the Cdc48 complex to ER-associated protein degradation , 2005, Nature Cell Biology.
[1216] Ann Richmond,et al. Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition , 2004, Cancer Research.
[1217] A. Ichihara,et al. cDNA cloning of rat proteasome subunit RC10‐II, assumed to be responsible for trypsin‐like catalytic activity , 1993, FEBS letters.
[1218] Masaki Yasukawa,et al. Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells1 , 2001, The Journal of Immunology.
[1219] Jeffrey W Jutai,et al. Age-related macular degeneration and low-vision rehabilitation: a systematic review. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[1220] U. Brunk,et al. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. , 2002, European journal of biochemistry.
[1221] Santhosh K. P. Kumar,et al. Ubiquitin-mediated degradation of active Src tyrosine kinase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[1222] N. Osna,et al. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. , 2003, Biochemical pharmacology.
[1223] J. Massagué,et al. Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.
[1224] Gabriella M. A. Forte,et al. Sec61p Is Required for ERAD-L , 2008, Journal of Biological Chemistry.
[1225] J. Hainfeld,et al. Binding of Amyloid β Protein to the 20 S Proteasome* , 1997, The Journal of Biological Chemistry.
[1226] B. Friguet,et al. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. , 1996, Archives of biochemistry and biophysics.
[1227] L. Nanney,et al. Increased epidermal growth factor receptors in melanocytic lesions. , 1992, Journal of the American Academy of Dermatology.
[1228] T. Taniguchi,et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.
[1229] K. Davies,et al. Protein degradation as an index of oxidative stress. , 1990, Methods in enzymology.
[1230] V. Herzog,et al. Endoplasmic reticulum-associated degradation: exceptions to the rule. , 2004, European journal of cell biology.
[1231] Bertrand Friguet,et al. The ubiquitin–proteasome system at the crossroads of stress-response and ageing pathways: A handle for skin care? , 2006, Ageing Research Reviews.
[1232] P. Lasch,et al. Hydrogen Peroxide-induced Structural Alterations of RNase A* , 2001, The Journal of Biological Chemistry.
[1233] L. Millen,et al. Conformational Remodeling of Proteasomal Substrates by PA700, the 19 S Regulatory Complex of the 26 S Proteasome* , 2002, The Journal of Biological Chemistry.
[1234] L. Neckers,et al. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors. , 2000, Biochemical pharmacology.
[1235] J. Adams. Development of the proteasome inhibitor PS-341. , 2002, The oncologist.
[1236] G. Buttin,et al. Twelve genes, including the unassigned proteasome ζ subunit gene, ordered within the human 1p13 region , 1998, Mammalian Genome.
[1237] G. Evan,et al. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. , 2007, Cancer cell.
[1238] H. Wiśniewski,et al. Lipopigment in the aging brain. , 1988, American journal of medical genetics. Supplement.
[1239] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[1240] N. Shastri,et al. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.
[1241] Wolfgang Baumeister,et al. The ATP-dependent HslVU protease from Escherichia coli is a four-ring structure resembling the proteasome , 1997, Nature Structural Biology.
[1242] T. Ruzicka,et al. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. , 2005, Arthritis and rheumatism.
[1243] D. Harman. Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.
[1244] W. Markesbery,et al. Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.
[1245] H. Qing,et al. Degradation of nicastrin involves both proteasome and lysosome , 2007, Journal of neurochemistry.
[1246] J. Sjöstrand,et al. Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract , 2003, Current eye research.
[1247] A. Brice,et al. Spinocerebellar ataxia 17 (SCA17) and Huntington’s disease-like 4 (HDL4) , 2008, The Cerebellum.
[1248] Yong Xia,et al. Proteasome Inhibition Down-regulates Endothelial Nitric-oxide Synthase Phosphorylation and Function* , 2006, Journal of Biological Chemistry.
[1249] Stavros J. Baloyannis,et al. Mitochondrial alterations Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.
[1250] A. Asai,et al. Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons , 2000, The Journal of Neuroscience.
[1251] T. Welling,et al. Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro. , 2000, Journal of vascular surgery.
[1252] E. Strickland,et al. Recognition of Misfolding Proteins by PA700, the Regulatory Subcomplex of the 26 S Proteasome* , 2000, The Journal of Biological Chemistry.
[1253] Hans Lehrach,et al. Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.
[1254] F. Holz,et al. [Age-related macular degeneration. 1. Epidemiology, pathogenesis and differential diagnosis]. , 1996, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[1255] Simon C Watkins,et al. The Hsp40 Molecular Chaperone Ydj1p, Along With the Protein Kinase C Pathway, Affects Cell-Wall Integrity in the Yeast Saccharomyces cerevisiae , 2007, Genetics.
[1256] H. Lehrach,et al. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.
[1257] A. Rosenblatt,et al. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. , 2000, Psychosomatics.
[1258] Wei Ping Wang,et al. Inhibition of proteasome function induced apoptosis in gastric cancer , 2001 .
[1259] A. Johnsen,et al. The human proteasome subunit HsN3 is located in the inner rings of the complex dimer. , 1995, Journal of molecular biology.
[1260] M. Beal,et al. Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.
[1261] Bruce Futcher,et al. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins , 1995, Nature.
[1262] U. Lendahl,et al. Pen-2 Is Sequestered in the Endoplasmic Reticulum and Subjected to Ubiquitylation and Proteasome-mediated Degradation in the Absence of Presenilin* , 2004, Journal of Biological Chemistry.
[1263] S. Wolff,et al. Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.
[1264] M. Jasin,et al. BRCA2 is required for homology-directed repair of chromosomal breaks. , 2001, Molecular cell.
[1265] P. Riederer,et al. Understanding Parkinson's disease. , 1997, Scientific American.
[1266] P. Williamson,et al. The Hsp70 member, Ssa1, acts as a DNA‐binding transcriptional co‐activator of laccase in Cryptococcus neoformans , 2006, Molecular microbiology.
[1267] L. Klotz,et al. Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts , 1997, FEBS letters.
[1268] B. Friguet,et al. Proteasome inactivation upon aging and on oxidation-effect of HSP 90 , 1997, Molecular Biology Reports.
[1269] A. Goldberg,et al. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. , 1999, Molecular cell.
[1270] C. Pickart,et al. Specificity of the Ubiquitin Isopeptidase in the PA700 Regulatory Complex of 26 S Proteasomes* , 1997, The Journal of Biological Chemistry.
[1271] M. Glickman,et al. Proteasome Disassembly and Downregulation Is Correlated with Viability during Stationary Phase , 2003, Current Biology.
[1272] I. Nemere,et al. The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems. , 2007, Current medicinal chemistry.
[1273] K. Reuhl,et al. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. , 1991, Toxicology and applied pharmacology.
[1274] A. Silman,et al. Scleroderma--demographics and survival. , 1997, The Journal of rheumatology. Supplement.
[1275] R. Bold,et al. Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. , 2001, The Journal of surgical research.
[1276] A. Haas,et al. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. , 1980, The Journal of biological chemistry.
[1277] W. Green,et al. IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.
[1278] D. Hood,et al. Mitochondrial biogenesis and the role of the protein import pathway. , 2003, Medicine and science in sports and exercise.
[1279] D. McConkey,et al. The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. , 2004, Molecular cancer therapeutics.
[1280] P. Beer-Romero,et al. Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[1281] R. Schekman,et al. Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes , 1995, Cell.
[1282] A. Goldberg,et al. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[1283] S. Matsufuji,et al. Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate. , 1993, The Biochemical journal.
[1284] M. Hochstrasser,et al. Membrane Topology of the Yeast Endoplasmic Reticulum-localized Ubiquitin Ligase Doa10 and Comparison with Its Human Ortholog TEB4 (MARCH-VI)* , 2006, Journal of Biological Chemistry.
[1285] A. Goldberg,et al. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.
[1286] H. Fernandez,et al. Monamine Oxidase Inhibitors: Current and Emerging Agents for Parkinson Disease , 2007, Clinical neuropharmacology.
[1287] K. Früh,et al. Rhesus Cytomegalovirus Contains Functional Homologues of US2, US3, US6, and US11 , 2005, Journal of Virology.
[1288] R. Vender,et al. Cystic Fibrosis Lung Disease in Adult Patients , 2008, Postgraduate medicine.
[1289] Y. Okawa,et al. Calpain inhibitor causes accumulation of ubiquitinated P-glycoprotein at the cell surface: possible role of calpain in P-glycoprotein turnover. , 1999, International journal of oncology.
[1290] H. Gilbert,et al. Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. , 1994, The Journal of biological chemistry.
[1291] C. Barlowe,et al. Sel1p/Ubx2p Participates in a Distinct Cdc48p‐Dependent Endoplasmic Reticulum‐Associated Degradation Pathway , 2006, Traffic.
[1292] W. Kaelin,et al. Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[1293] K. Davies,et al. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. , 1987, The Journal of biological chemistry.
[1294] R. Perez-soler,et al. Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells* , 2003, Journal of Biological Chemistry.
[1295] P. Ponka. Hereditary Causes of Disturbed Iron Homeostasis in the Central Nervous System , 2004, Annals of the New York Academy of Sciences.
[1296] C. Slaughter,et al. Formation of Proteasome-PA700 Complexes Directly Correlates with Activation of Peptidase Activity , 1998, Microscopy and Microanalysis.
[1297] P. Kloetzel,et al. The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes , 1999, FEBS letters.
[1298] B. Müller-Myhsok,et al. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. , 2002, American journal of human genetics.
[1299] K. Davies,et al. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.
[1300] Randal J. Kaufman,et al. Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.
[1301] T. Kuwana,et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.
[1302] K. Scherrer,et al. The prosomes (multicatalytic proteinases; proteasomes) and their relationship to the untranslated messenger ribonucleoproteins, the cytoskeleton, and cell differentiation. , 1994, Progress in nucleic acid research and molecular biology.
[1303] Yixian Zheng,et al. The Cdc48/p97-Ufd1-Npl4 Complex: Its Potential Role in Coordinating Cellular Morphogenesis During the M-G1 Transition , 2004, Cell cycle.
[1304] E. Hol,et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation , 2002, The Journal of cell biology.
[1305] Shih-Yi Lin,et al. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. , 2005, American journal of physiology. Endocrinology and metabolism.
[1306] Lance F. Barton,et al. Immune Defects in 28-kDa Proteasome Activator γ-Deficient Mice1 , 2004, The Journal of Immunology.
[1307] The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses1 , 2000, The Journal of Immunology.
[1308] D. Harman,et al. Lipofuscin and ceroid formation: the cellular recycling system. , 1989, Advances in experimental medicine and biology.
[1309] H. Qing,et al. Ubiquitin–proteasome pathway mediates degradation of APH‐1 , 2006 .
[1310] R. Hampton,et al. Cue1p Is an Activator of Ubc7p E2 Activity in Vitro and in Vivo* , 2008, Journal of Biological Chemistry.
[1311] D. Pellman,et al. Deubiquitinating enzymes: a new class of biological regulators. , 1998, Critical reviews in biochemistry and molecular biology.
[1312] A. Bruce-Keller,et al. LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. , 2006, Antioxidants & redox signaling.
[1313] S. Ōmura,et al. Proteasome-dependent regulation of p21WAF1/CIP1 expression. , 1996, Biochemical and biophysical research communications.
[1314] V. Ravindranath,et al. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α‐lipoic acid , 2007 .
[1315] L. Dick,et al. Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured Cells* , 1997, The Journal of Biological Chemistry.
[1316] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[1317] J. Dobson,et al. Beta-adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation. , 2003, American journal of physiology. Heart and circulatory physiology.
[1318] U. Brunk,et al. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. , 2002, Free radical biology & medicine.
[1319] A. Varshavsky,et al. In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.
[1320] H. Band,et al. Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. , 1998, International immunology.
[1321] C. Ross,et al. Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant α-synuclein enhances H2O2- and Sin-1-induced cell death , 2007, Neurobiology of Aging.
[1322] W. J. Cromartie,et al. Arthritis in rats after systemic injection of streptococcal cells or cell walls , 1977, The Journal of experimental medicine.
[1323] S. Beck,et al. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.
[1324] A. Vitiello,et al. Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.
[1325] K. Nakanishi,et al. A2E, a fluorophore of RPE lipofuscin, can destabilize membrane. , 2006, Advances in experimental medicine and biology.
[1326] R. Busse,et al. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. , 1997, Hypertension.
[1327] R. Roos,et al. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases , 2007, Molecular and Cellular Neuroscience.
[1328] G. Bartosz,et al. Oxidative modifications of protein structures. , 2000, Advances in clinical chemistry.
[1329] C. Franceschi,et al. Fibroblast cultures from healthy centenarians have an active proteasome , 2000, Experimental Gerontology.
[1330] A. Goldberg,et al. Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.
[1331] C. Hill,et al. Characterization of Recombinant REGα, REGβ, and REGγ Proteasome Activators* , 1997, The Journal of Biological Chemistry.
[1332] A Hofman,et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.
[1333] K. Tanaka,et al. Sequence analyses and inter-species comparisons of three novel human proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential proteolytic active-site residues. , 1994, Biochimica et biophysica acta.
[1334] J. W. Margolis,et al. Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor. , 1995, Archives of biochemistry and biophysics.
[1335] Jiangping Wu. On the Role of Proteasomes in Cell Biology and Proteasome Inhibition as a Novel Frontier in the Development of Immunosuppressants , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[1336] K. Mulder,et al. Modulation of Ubc4p/Ubc5p-Mediated Stress Responses by the RING-Finger-Dependent Ubiquitin-Protein Ligase Not4p in Saccharomyces cerevisiae , 2007, Genetics.
[1337] Dean P. Jones. Redox potential of GSH/GSSG couple: assay and biological significance. , 2002, Methods in enzymology.
[1338] K Tanaka,et al. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. , 2000, Biochemical and biophysical research communications.
[1339] D. S. Lind,et al. Nuclear factor-κB is upregulated in colorectal cancer , 2001 .
[1340] J. Scheller,et al. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts , 2008, Journal of Neuroimmunology.
[1341] Benjamin Geiger,et al. Down-Regulation of β-Catenin by Activated p53 , 2001, Molecular and Cellular Biology.
[1342] L. Formigli,et al. Expression of E-selectin in ischemic and reperfused human skeletal muscle. , 1995, Ultrastructural pathology.
[1343] K. Lim,et al. Autophagy-mediated clearance of aggresomes is not a universal phenomenon. , 2008, Human molecular genetics.
[1344] C. Olanow,et al. Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease , 2002, Neuroscience Letters.
[1345] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[1346] K. Ferrell,et al. Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.
[1347] James M. Roberts,et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.
[1348] A. Wandinger-Ness,et al. The Proteasome α-Subunit XAPC7 Interacts Specifically with Rab7 and Late Endosomes* , 2004, Journal of Biological Chemistry.
[1349] S. French,et al. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. , 2004, Experimental and molecular pathology.
[1350] P. Kloetzel,et al. PI31 is a modulator of proteasome formation and antigen processing , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[1351] H. Lehrach,et al. Linkage of TATA-binding protein and proteasome subunit C5 genes in mice and humans reveals synteny conserved between mammals and invertebrates. , 1997, Genomics.
[1352] K. Satoh,et al. Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation , 2000, Brain pathology.
[1353] Y. Ye. Inaugural article : recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane , 2005 .
[1354] Fangyi Zhang,et al. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.
[1355] M. Orłowski,et al. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. , 1992, Biochemistry.
[1356] F. Blattner,et al. Sequence analysis of four new heat-shock genes constituting the hslTS/ibpAB and hslVU operons in Escherichia coli. , 1993, Gene.
[1357] K. Davies,et al. Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome* , 2003, The Journal of Biological Chemistry.
[1358] A. Chaffotte,et al. Proteasome Inhibition in Glyoxal-treated Fibroblasts and Resistance of Glycated Glucose-6-phosphate Dehydrogenase to 20 S Proteasome Degradation in Vitro * , 2001, The Journal of Biological Chemistry.
[1359] R. Hough,et al. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. , 1987, The Journal of biological chemistry.
[1360] S. Bassnett. On the mechanism of organelle degradation in the vertebrate lens. , 2009, Experimental eye research.
[1361] Tobias Jung,et al. The proteasome and its role in the degradation of oxidized proteins , 2008, IUBMB life.
[1362] L. Pasquini,et al. Relationship between β-amyloid degradation and the 26S proteasome in neural cells , 2003, Experimental Neurology.
[1363] F. Shang,et al. Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. , 2001, Experimental eye research.
[1364] H. Nakase,et al. Abnormal dentatorubral-pallidoluysian atrophy (DRPLA) protein complex is pathologically ubiquitinated in DRPLA brains. , 1999, Biochemical and biophysical research communications.